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Supervisor:  Jonathan L. Sessler 
 
The dissertation focuses on the recent discovery in supramolecular chemistry of 
novel macrocyclic compounds with NH and CH donor groups. Chapter 1 provides a brief 
overview of the anions under study, supramolecular chemistry, the relevant other anion 
receptors, as well as previous findings involving the use of CH donor groups as 
functional building blocks. Chapter 2, as the major focus of this dissertation, describes a 
pyrrolyl-based triazolophane, incorporating CH and NH donor groups, which acts as a 
receptor for the pyrophosphate anion in chloroform solution. It shows selectivity for this 
trianion, followed by HSO4− > H2PO4− > Cl− > Br− (all as the corresponding 
tetrabutylammonium salts), with NH−anion interactions being more important than 
CH−anion interactions. In the solid state, the receptor binds the pyrophosphate anion in a 
clip-like slot via NH and CH hydrogen bonds. Chapter 3 describes a pyrrole–based 
triazolium–phane which has been prepared through “click” chemistry in moderate yield. 
It displays a high selectivity for tetrahedral oxyanions relative to various test monoanions 
and trigonal planar anions in mixed polar organic–aqueous solvent media. It was also 
found that the binding affinity and selectivity of the macrocycle to the anions are solvent 
dependent. Several crystal structures were solved. They confirm that the cationic 
 viii 
macrocycle ring binds pyrophosphate and phosphate anions in the solid state. Finally, 
chapter 4 describes a novel 1,3,4-substituted 1,2,3-triazolium salt found to function as an 
effective precursor for the synthesis of structurally characterized cationic silver(I) and 
ruthenium(II) carbene complexes of overall 1:2 ligand-to-metal stoichiometry. The Ag(I) 
complex crystallized in the form of an eight silver atom containing cluster, whereas the 
Ru(II) complex proved to be a discrete species and was found to be capable of initiating 
the ring-opening metathesis polymerization of norbornene upon activation with 
(trimethylsilyl)diazomethane. 
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Chapter 1: Introduction 
1.1 ANIONS 
Anions are ubiquitous in the natural world. They have significant importance in 
chemistry, biology and environment, comprising the electron rich half of all ionic 
compounds. Their study has gained a tremendous attention in the last half century due to 
widespread deleterious effects. Sulfate is prominent as a toxic, troublesome species 
which causes acid rain.1 Nitrate is the most abundant chemical contaminant in the world’s 
ground water, because of its agricultural fertilizer runoff.2 Nitrates and nitrites are used as 
widespread preservatives in meat, and are precursors in the formation of N-nitroso 
compounds (NOC), a class of genotoxic compounds, most of which are animal 
carcinogens.3 The increasing amount of phosphate in rivers coming from factories and 
fertilizers present a problem, which leads to the eutrophication of waterways and the 
production of toxic algal blooms.4 Pertechnetate, a radioactive product of nuclear fuel 
reprocessing, constitutes a major pollution hazard.4 
Anions are critical to the maintenance of life and also play important roles in a 
range of biological processes. Indeed, the recognition, transport, or transformation of 
anions is involved at some level in almost every conceivable biochemical operation. ATP 
and other high-energy anionic phosphate derivatives are at the center of power processes 
as diverse and important as biosynthesis, molecular transport, and muscle contraction.1 
Pyrophosphate is the product of ATP hydrolysis under cellular conditions and is involved 
in DNA replication catalyzed by DNA polymerase.5 The detection of pyrophosphate is 
thus being explored as a real time DNA sequencing method, a line of investigation that 
has implications in cancer research.6 Its analogue, inorganic phosphate, has physiological 
relevance in biological energy storage and signal transduction. It is also a structural 
component in teeth and bones.7 
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Compared to cations, the design of anion receptors is particularly. There are a 
number of reasons for this. (1) Anions are larger than the equivalent isoelectronic cations, 
resulting in a lower charge to radius ratios.8 The more diffuse nature of anions was the 
consequence that electrostatic binding interactions for anions are less effective than for 
the corresponding isoelectronic cations(Table 1.1). (2) Most anions are pH sensitive, 
many become protonated at low pH and lose their negative charge. Thus, receptors need 
to function within the pH window of their targeted anion. (3) Anions have a wide range 
of geometries (Figure 1.1).1 Therefore, a better design of receptors is required to select 
for a particular anionic guest than is true for most simple cations. (4) Anions can be well-
solvated in the polar protic solvents and they have large hydration energies (Table 1.1),9 
which make anions difficult to extract out of aqueous environments. 
  
Table 1.1: A comparison of the radii (r) and hydration energies (∆Ghyd) of selected 
isoelectronic anions and cations9 
Anion r (Å) ∆Ghyd 
(kJ/mol) 
Cation r (Å) ∆Ghyd 
(kJ/mol) 
F- 1.19 -465 Na+ 1.16 -365 
Cl- 1.67 -340 K+ 1.52 -295 
Br- 1.82 -315 Rb+ 1.66 -275 















1.2 SUPRAMOLECULAR CHEMISTRY 
Supramolecular chemistry is a highly interdisciplinary field of science covering 
the chemical, physical, and biological features of chemical species of greater complexity 
than simple molecules.10 This relatively young area has extended into organic chemistry 
and the synthetic procedures for molecular construction. It also touches on coordination 
chemistry and metal ion-ligand complexes. It is relevant to physical chemistry and the 
experimental and theoretical studies of interactions. It can provide insights into 
biochemistry and biological processes that relate to substrate binding and recognition. 
Finally, supramolecular chemistry is extending its reach into materials science and the 
mechanical properties of solids.  
In the broadest terms, supramolecular chemistry involves the study of 
noncovalent intermolecular interactions, which are generally weak and reversible in 
nature.11 These interactions involve interalia hydrogen bonding, electrostatic effects, 
hydrophobic forces, van der Waals forces, π -π interactions, cation-π or anion-π 
interactions, and metal-ligand interactions. Of these forces, hydrogen bonding 
interactions are probably the most important. One of the most recognizable 
supramolecular systems is DNA, where self-complementary Watson-Crick hydrogen 
bonding interactions dictate specific base-pairing modes (Figure 1.2). 
 
 
Figure 1.2: Canonical Watson-Crick base-pairing modes. 
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1.2.1 Hydrogen Bonding 
Hydrogen bond is a weak electrostatic chemical bond which forms between 
covalently bonded hydrogen atoms and a strongly electronegative atom with a lone pair 
of electrons. A hydrogen bond is therefore the attractive force that arises between the 
donor covalent pair X-H in which a hydrogen atom H is bound to a more electronegative 
atom X i.e. O or N, and other non-covalently bound nearest neighbor electronegative 
acceptor atoms A.  
 
A can be variety of species. Most common are N and O in biology; A can also be a 
negatively charged anion or even a π -electron containing species. Moreover, C-H 
hydrogen bonds have also been observed which will be discussed in detail in this 
dissertation. Hydrogen bonding interactions can be classified in terms of their energy.12 
The strongest interactions (15-40 kcal/mol) have significant covalent character between 
both electronegative atoms and the shared H, and typically involve O–H‧‧‧A- and N–H‧
‧‧N+ contacts. Medium range hydrogen bonding interactions (4-15 kcal/mol) are 
dominated by electrostatics, and often involve X–H‧‧‧O and X–H‧‧‧N contacts. 
Finally, at the low end of the energetic range (0.5<4 kcal/mol) are weakly electrostatic 
and dispersion-repulsion driven, such as hydrogen bonds of the X–H‧‧‧π type. The 
distance for X–H and A‧‧‧H also depend on the strength of the hydrogen bond. The 
distance from donor to acceptor can range from 2.2-4.0 Å. The location of the hydrogen 
atom depends on the electronegativity of the competing species.  
Hydrogen bonds have been exploited in supramolecular chemistry where kinetics, 
reversibility, and orientation are critical. This utility reflects their non-covalent nature and 
their directionality. Of importance to this dissertation are the hydrogen bonds of the N–H
 6 
‧‧‧A-, C–H‧‧‧A-, and (C–H)+‧‧‧A- types, which are likely from pyrrole, triazole and 
triazolium donor subunits, respectively, with A- being the anion of interest. 
 
1.3 SYNTHETIC ANION RECEPTOR 
One of the goals of supramolecular chemistry is to understand the interactions 
between guest anions and host supramolecules. This context, a big challenge is to 
sequester, transfer, and sense selectively anionic species. The inherent interest in these 
phenomena as well as the potential practical benefits of supramolecular anion recognition 
chemistry, help explain why synthetic anion receptor chemistry has emerged as one of the 
fastest growing areas in supramolecular chemistry in recent years.1,13-17 
Anion receptors can be classified into different forms. Many lewis acids and 
proton donor motifs fall into the neutral category; Transition metals, protonated nitrogen 
and heterocyclic species provide cationic charges. Anion receptors include neutral 
amides, thioamides, sulfonamides, ureas, thioureas, phenols, pyrroles, carbazoles, and 
indoles, as well as charged species, such as ammoniums, guanidiniums, pyridiniums, 





Figure 1.3: Hydrogen bond donors found in nature and used in supramolecular 
chemistry. 
 
1.4 NEUTRAL C-H‧‧‧ANION HYDROGEN BONDS 
The used of non-covalent interactions involving C-H hydrogen bond donors12 
took longer to gain acceptance for anion recognition than more traditional N-H and O-H 
donors. However, it is interesting to note that the possibility18 of a CH hydrogen bond 
was first described in 1935, at the same time as traditional ones.19 However, they were 
mentioned only occasionally in the literature until a systematic study involving the crystal 
structures of purines and pyrimidines was carried out in the 1960s.20 Further 
investigations of them faltered momentarily after strong comments against the possibility 
of C-H based hydrogen bonds. Until a landmark analysis of crystallographic evidence for 
CH hydrogen bonds,21 investigations culminated in a comprehensive and authoritative 
text about CH hydrogen bond donors which are entitled as “the weak hydrogen bond”.12 
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The book focuses on C-H‧‧‧O interactions, while the discussions there are applicable to 
other hydrogen-bond acceptors, such as anions. 
The awareness and use of neutral C-H hydrogen bonding in anion supramolecular 
chemistry started with observations of close C-H‧‧‧anion contacts in crystal structures. 
The first discovery of note for neutral systems involved fluoride anion receptors22 (e.g., 1, 
Scheme 1.1a) where aliphatic –CH2– groups are polarized by highly electronegative 
oxygen and fluorine atoms. In the second example, aliphatic -CH2- groups were 
implicated as stabilizing secondary interactions in macrobicyclic receptors (2, Scheme 
1.1b).23 At the same time, computational investigations played a large role in emphasizing 
the strength24,25 and tunability26 of aromatic (Scheme 1.1c) and aliphatic C-H‧‧‧anion 
hydrogen bonds arising from neutral functional groups. 
 
 
Scheme 1.1:   Early discoveries of C–H‧‧‧anion interactions in (a) macrocyclic and 
(b) macrobicyclic receptors, and, (c) recent theoretical works, helped to 
stimulate experimental studies of anion binding.51 
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In 2008, a number of studies aimed involving neutral C-H‧‧‧anion interactions 
were published.27-34 The first of these reports investigated the gas-phase binding of 
various anions using a cavitand-based receptor (3, Scheme 1.2).27 In this case, the 
involved in CH-anion hydrogen bonds were methylene units activated by adjacent 
electronegative oxygen atoms. The second receptor involved the use of a strapped 
calix[4]pyrrole (4, Scheme 1.2)31 and electron deficient receptors (5, Scheme 1.2)32 to 
promote aromatic and aliphatic C-H‧‧‧anion interactions. Here, evidence of interaction 
was inferred from enhancement in the anion affinity or from the shifts in the C-H proton 
resonances seen upon binding. At the same time, computational studies were carried out 
to interpret those experimental data. A third development involved the discovery of anion 
binding promoted by the 1,2,3-triazole unit in both macrocyclic receptors (6-9, Scheme 
1.2)28,33 and foldamer-based receptors (10-13, Scheme 1.2).28-30 The investigations of the 
triazole-based anion recognition arose in independent laboratories. This highlights the 





Scheme 1.2:   Receptor systems involved in seminal CH-anion recognition work from 
2008: cavitands (3), strapped calix[4]pyrroles (4), electron deficient 
receptors (5), triazolophanes (6–9), aryl-triazole oligomers (10, 11), and 










1.5 CATIONIC (C-H)+‧‧‧ANION HYDROGEN BONDS 
Most positively charged anion receptors have ammonium, protonated pyrrole or 
guanidinium groups as binding sites and interact with targeted anions via (N-H)+‧‧‧A- 
hydrogen bonds and electrostatic interactions.14,35 In recent years, relatively new cationic 
subunits for anion recognition have been introduced, namely the 1,3-disubstituted 
imidazolium motif and 1,4-disubstituted 1,2,3-triazolium motif. Receptors based on the 
imidazolium and triazolium cations stabilize the corresponding anion complexes via a 
combination of electrostatic interactions and (C-H)+‧‧‧A- hydrogen bonds. Imidazolium 
and triazolium–based receptors offer a significant advantage, namely the possibility of 




Imidazolium group can stabilize a strong interaction with anions through (C-H)+‧
‧‧A- type ionic hydrogen bonds due to charge-charge electrostatic interactions. The 
presence of these interactions was inferred from the crystal structures of imidazolium 
based ionic liquids36(a),(b) and calix[4]pyrroles complexing with imidazolium salts.36(c) In 
1994, Welton and co-workers provided evidence that receptor 1 can interact with halide 
anions in solution as inferred from multinuclear NMR spectroscopic measurement 
(Figure 1.4).37 It was found that the series of complexes 1-X (X = Cl-, Br-, and I-) 
displayed distinct CH resonances in their respective 1H and 13C NMR spectra as recorded 
in CDCl3. The greatest differences observed are the signals for the C(2)H group located 
between the two imidazolium nitrogen atoms. Subsequently, Sato and coworkers reported 
a benzene-based tripodal imidazolium receptor for anion recognition (2, Figure 1.4).38 
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Later on, various types of receptors containing imidazolium moieties were reported, such 
as imidazolium cyclophanes (3, Figure 1.4),39 calix-imidazoliums (4, Figure 1.4),40 
imidazolium anthracenes (5, Figure 1.4),41 imidazolium calix[4]arenes (6, Figure 1.4),42 
imidazolium cavitands (7, Figure 1.4)43 and imidazolium polythiophenes (8, Figure 1.4).44 
All these receptors utilized the imidazolium moieties as the binding sites for anions. 
However, the different hosts in question provided different binding properties with 
anions, presumably as the result of the various binding pockets stabilized by framework 
in question.  
 




The copper(I)–catalyzed azide alkyne 1,3–dipolar cycloaddition (CuAAC)–one of 
the prime examples of the concept of highly efficient and modular reactions named 
“click” chemistry45–has been applied in the area of biological, materials, and medicinal 
chemistry.46 In 2008, Albrecht and co-workers first reported the synthesis of 1,2,3-
triazolylidenes as highly modular precursors for a new class of carbenes and their 
coordination chemistry with a variety of transition metals (Pd, Ru, Rh, and Ir).47 Besides 
their participation in transition-metal coordination chemistry, the unique properties of the 
1,4-disubstituted 1,2,3-triazolium ring have attracted attention in the area of anion 
recognition as a result of the ability of this subunit to stabilize triazolium (C-H)+‧‧‧anion 
hydrogen bonds. Nevertheless, even today there are very few reports involving the use of 
positively charged triazolium motifs for anion recognition. In 2008, Pandey and co-
workers reported a set of cyclic and acyclic bile acid-based 1,2,3-triazolium receptors that 
displayed a remarkable ability to recognize anions through (C-H)+‧‧‧anion hydrogen 
bond interactions (1, Figure 1.5).48 In 2009, Beer and co-workers reported the first 
examples wherein the 1,2,3-triazolium group was exploited for the anion templated 
formation of pseudorotaxane and rotaxane assemblies (2, Figure 1.5).49 These systems are 
of interest because they exhibit rare selectivity for bromide over chloride. Later on, 
Schubert and co-workers designed mono- and bis-tridentate ligands employing the 
triazolium motif and showed that the systems in question could complex sulfate ions via a 
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Chapter 2: A Pyrrolyl-Based Triazolophane: A Macrocyclic Receptor 




Pyrophosphate detection has aroused interest in the scientific community not only 
because pyrophosphate is the product of ATP hydrolysis under cellular conditions1 but 
also because it could afford a means of effecting real-time DNA sequencing.2 
Pyrophosphate monitoring may also have a role to play in cancer research since this 
anion is involved in DNA replication catalyzed by DNA polymerase.3 Pyrophosphate is 
also of interest as a larger, more highly charged analogue of inorganic phosphate (H2PO4-
/HPO42-), which has physiological relevance in biological energy storage and signal 
transduction, in addition to being a structural component in teeth and bones.4 Not 
surprisingly, therefore, considerable effort has been devoted recently to the development 
of synthetic receptors that allow for the recognition, detection, or extraction of 
pyrophosphate and related species, such as inorganic phosphate.5 Systems incorporating 
neutral or cationic NH hydrogen bond donor groups (e.g., pyrrole, indole, ammonium, 
and guanidinium) or cationic CH hydrogen bond donor motifs (e.g., imidazolium and 
triazolium) have been particularly effective in this regard. However, to the best of our 
knowledge, receptors with neutral CH H-bond donors have yet to be exploited for the 
purpose of pyrophosphate (or phosphate) anion recognition.  
CH bonds are present in the overwhelming majority (97%) of chemical 
compounds.6 Nevertheless, it is only recently that the importance of CH H-bonds in 
biological and artificial anion recognition has come to be appreciated.7 In recent 
pioneering work, Flood and co-workers reported the synthesis and anion binding 
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properties of [34]triazolophanes (Figure 2.1). These new macrocycles have a diameter of 
about 3.8 Å and display a high affinity for the chloride ion.7c On the basis of this and 
previous theoretical and experimental studies,8 it was suggested that the strength of 
neutral, triazole-derived C-H· · ·X- (X- = halide) bonds can approach those of more 
traditional NH donors, such as pyrrole. We thus considered it of interest to combine both 
these recognition motifs within the same macrocyclic framework. In this chapter, the 
synthesis and anion binding properties of the first such system, namely the calix[2]1,3-
bis(pyrro-2-yl)(1,4)-1,2,3-triazolo-phane (2.1) are detailed. As discussed below, this 
system acts as a highly effective receptor for the pyrophosphate anion, both in the solid 
state and in organic media.9 Our findings, supported by theory, provide support for the 
conclusion that NH-anion bonding interactions are more important than CH-anion 
interactions, at least in highly symmetric receptor systems incorporating both motifs. 
 
 
Figure 2.1: Chemical structure of the [34]triazolophanes reported by Flood.7(c) 
 
2.2 RESULTS AND DISCUSSIONS 
The synthesis of 2.1 is shown in Scheme 2.1. Using “click” chemistry conditions, 
a copper-catalyzed Huisgen 1,3-dipolar cycloaddition10 was used to couple the bis-azide 
2.27(c) with alkyne 2.327. This was followed by t-BOC deprotection11 to give 1,3-bis(pyrro-
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2-yl)-(1,4)-1,2,3-triazolobenzene (2.4) in 24% combined yield for two steps. 
Condensation of 2.4 with acetone12 produced 2.1 in 10% yield.  
 
Scheme 2.1: Synthesis of Macrocycle 2.1a 
 
Conditions: a (a) CuSO4, sodium ascorbate, EtOH/H2O/toluene (7:3:1); (b) NaOC(CH3)3, anhydrous THF; 
(c) acetone, TFA, Ar, RT. 
NOESY spectroscopic studies provided support for the notion that 2.1 has a 
flexible conformation at ambient temperature. This was further verified by variable 
temperature 1H NMR spectroscopic studies; specifically, signals that became broader 
with decreasing temperature were observed (Figure 2.8). 
A single crystal X-ray diffraction analysis of 2.1 revealed a nearly flat structure, 
wherein the pyrrole NH protons on N5 and N5A point out from the center of the core. 
The distance between the exocyclic C-H or N-H and the nitrogen atoms on the 
neighboring triazole ring generally proved to be less than 3 Å. This leads us to suggest 
that intramolecular H-bonding interactions on the exterior of the ring7r help stabilize the 
observed planar conformation in the solid state (Figure 2.2). 
The anion properties of 2.1 in solution were first analyzed using UV-vis 
spectroscopy. Standard titrations, associated curve fittings,13 and Job plots provided 
support for pyrophosphate (as the tetrabutylammonium (TBA) salt) being bound to 2.1 
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strongly in chloroform at 300 K (Ka = (2.30 ± 0.40) × 106 M-1) and with a 1:1 binding 
stoichiometry. Mass spectrometric analyses also provided support for the conclusion that 




Figure 2.2: (a) Top and (b) side views of the single crystal X-ray structure of           
2.1·4CH3OH·H2O. All solvent molecules have been omitted for clarity. 
(Crystals used in this study were obtained by the author; The data were 
collected by the author; The crystal refinement was done by Dr. Xiaoping 
Yang.)  
The association constants (Ka) between receptor 2.1 and various other test anions 
were also determined in chloroform using standard UV-vis absorption titration method. 
Among the test anions considered, receptor 2.1 displays selectivity for the trianionic 
pyrophosphate anion, followed by HSO4- ((4.98 ± 0.40) × 105) > H2PO4- ((2.38 ± 0.25) × 
105) > Cl- ((1.18 ± 0.07) × 104) > Br- ((2.64 ± 0.09) × 103) (all as TBA salts). Macrocycle 
2.1 thus displays a high pyrophosphate/dihydrogenphosphate selectivity (Ka(HP2O73-
)/Ka(H2PO4-) = 10). 
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The host-guest interactions between macrocycle 2.1 and the pyrophosphate anion 
were further analyzed by 1H NMR spectroscopy. Specifically, a solution of 2.1 (5 mM, 
CDCl3) was titrated with up to 10 equiv. of (TBA)3HP2O7 (Figure 2.3). The hydrogen 
signals for the pyrrole NH, the triazole CH, and the endocyclic hydrogen atom of the N1-
linked phenyl unit were seen to shift downfield by 5.09, 1.96, and 1.22 ppm, respectively 
(Figure 2.3). These changes followed the sequence of expected H acidity, namely pyrrole 
NH > triazole CH > benzene CH.14 Thus the trends observed in the NMR spectral studies 
are consistent with the intrinsic strength of the various H-bond donor groups as inferred 
from electronic structure calculations carried out with chloride anion. The binding 
energies (MP2/aug-cc-pVDZ) were computed by our collaborator, Dr. Benjamin Hay. 
For the complexes of chloride with pyrrole N-H, triazole C-H, and benzene C-H donors, 
the resulting energies are -22.50, -18.94, and -8.42 kcal mol-1, respectively (cf. Section 
2.4.7).15 They are also consistent with the hydrogen bond distances observed in the solid 
state (see below). Nevertheless, it is important to appreciate that all three hydrogen bond 
donor motifs play a role in the observed anion recognition. In contrast, only a small 
downfield shift was seen for the signals ascribed to the exocyclic hydrogen atoms on the 
phenyl and pyrrole rings (∆δ = 0.09 and 0.10 ppm, respectively); apparently these C-H 




Figure 2.3: 1H NMR spectra (aromatic region) of 2.1 recorded upon titration with 
(TBA)3HP2O7; CDCl3, 300 K. 
 
Additional support for the suggestion that both NH and neutral CH interactions 
combine to effect pyrophosphate anion recognition in the case of receptor 2.1 came from 
a single crystal X-ray diffraction analysis of the complex formed between pyrophosphate 
and 2.1 (2.1 ·(TBA)3HP2O7 ·3H2O) (Figure 2.4). In this complex, the macrocycle displays 
a folded conformation; this provides a clip-like slot into which the pyrophosphate anion 
inserts. All the pyrrole NH, triazole CH, and endocyclic benzene CH protons point into 
the center of the ring and are involved in hydrogen bond interactions with the bound 
pyrophosphate guest, as inferred from bond distances (pyrrole NH· · ·O ca. 1.9 Å, triazole 
CH· · ·O ca. 2.3 Å, benzene CH· · ·O ca. 3.7 Å). The resulting conformation thus stands 




Figure 2.4: (a) Top and (b) side views of a single-crystal X-ray diffraction structure of 
2.1·TBA3HP2O7·3H2O in which the pyrophosphate anion is in a space filling 




In summary, the pyrrolyl-based receptor 2.1 has been prepared in a moderate 
yield. It binds the pyrophosphate anion in the solid state and displays a high selectivity 
for this trianion relative to various test monoanions in chloroform solution. The present 
results thus serve to underscore the utility of new recognition motifs in the design of 
anion binding agents, particularly those that combine both CH- and NH-anion 
interactions within a single framework. The present work also helps calibrate directly the 




2.4 EXPERIMENTAL SECTION 
2.4.1 General Procedures 
All reagents and starting materials were obtained from commercial suppliers and 
used as received unless otherwise noted. Column chromatography was performed on 
silica gel (40-63 µm, Silicycle, Canada) and Alumina N (50-200 µm, Dynamic 
Adsorbents Inc., USA). Nuclear magnetic resonance (NMR) spectra were recorded on 
Varian Mercury 400, Varian Inova 500, and Varian DirectDrive 600 instruments. UV-vis 
spectra were recorded on a Cary 5000 UV-Vis-NIR Spectrophotometer. Low resolution 
ESI mass spectra were measured using either a Finnigan LCQ Quadrupole Ion Trap Mass 
Spectrometer or a Thermo LTQ-XL linear Ion Trap Mass Spectrometer. High resolution 
ESI mass spectra were obtained on an Ion Spec Fourier Transform mass spectrometer 
(9.4 T). 
 
2.4.2 Synthetic Experimental 
1,3-Bis(pyrro-2-yl)(1,4)-1,2,3-triazolobenzene, 2.4: A solution of the 3,5-
diazido-1-tert-butylbenzene 2.2 (432.2 mg, 2.0 mmol), and 2-ethynylpyrrole-1-carboxylic 
acid tert-butyl ester 2.3 (840.8 mg, 4.4 mmol), sodium ascorbate (40.0 mg, 0.2 mmol), 
and CuSO4 (5.0 mg, 0.02 mmol) in a mixture of 14 mL EtOH, 6 mL H2O and 2 mL 
toluene was stirred at ambient temperature for 24 hrs. After removal of the solvents in 
vacuo, a brown solid was obtained. This solid was dissolved in CH2Cl2 and washed with 
water (3 × 30 mL). The aqueous phase was extracted twice with CH2Cl2 (2 × 50 mL). The 
organic extracts were combined and dried over MgSO4 and then concentrated under 
reduced pressure. The brown solid obtained as a result was then dissolved in anhydrous 
THF and treated with 10 eqiv. sodium tert-butoxide and left to stir overnight. The 
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volatiles were removed in vacuo and the brown solid obtained was washed with water 
(3×30 mL), extracted with ethyl acetate (2×50 mL), dried over MgSO4 and concentrated 
under reduced pressure. The crude product was purified by column chromatography 
(alumina neutral, CH2Cl2:CH3OH, 10:0.1, eluent) and recrystallized from THF and 
hexane to afford 188 mg (24%, 0.47 mmol) of 2.4 as a pale brown solid. 1H NMR 
(DMSO-d6, 400 MHz) [ppm], δ 11.52 (s, 2 H, NH), 9.11 (s, 2 H, -N-CH=C-), 8.35 (t, 
J=1.8 Hz, 1 H, CH), 8.03 (d, J=1.8 Hz, 2 H, CH), 6.87 (dd, J1=4.0 Hz, J2=2.4 Hz, 2 H, 
pyrrole-α-H), 6.51 (m, 2 H, pyrrole-β-H), 6.16 (dd, J1=5.8 Hz, J2=2.7 Hz, 2 H, pyrrole-
β-H), 1.45 (s, 9 H, CH3); 13C-NMR (d-DMSO, 100 MHz) [ppm], δ 31.0, 35.6, 106.7, 
109.0, 109.1, 116.8, 117.8, 119.5, 122.0, 137.7, 142.8, 155.4; MS (HR-ESI) Calcd. for 
C22H23N8 (M+H+) 399.2046; Found 399.2038 (M+H+). 
 
Calix[2]1,3-bis(pyrro-2-yl)(1,4)-1,2,3-triazolo-phane, 2.1: Compound 2.4 (500 
mg, 1.256 mmol) in acetone (250 mL) was placed in a 1000 mL three-way round bottom 
flask and degassed for 30 min by bubbling with argon. While flushing the reaction vessel 
with argon, TFA (20 mL, 0.267 mol) was then added dropwise. The resulting solution 
was then stirred for 3 hours at ambient temperature before being quenched via the 
addition of solid NaOH (11 g, 0.275 mol). Evaporation of the reaction mixture afforded a 
brown solid. To this crude product, dichloromethane (100 mL) and water (100 mL) were 
added. The organic phase was then separated off and washed three times with water 
(3×100 mL). The organic layer was dried over anhydrous MgSO4 and evaporated in 
vacuo to yield a brown solid. This brown solid was purified by column chromatography 
(silica gel, CH2Cl2:CH3OH, 10:0.1, eluent) and then followed by recrystallization from 
CHCl3 and CH3OH to give 54 mg (10%, 0.062 mmol) of 2.1 as a white solid. 1H NMR 
(CDCl3, 400 MHz) [ppm], δ 8.88 (s, 4 H, NH), 8.01 (s, 4 H, -N-CH=C-), 7.83 (d, J=2.4 
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Hz, 4 H, CH), 7.68 (t, J=2.0 Hz, 2 H, CH), 6.47 (m, 4 H, pyrrole-β-H), 6.21 (m, 4 H, 
pyrrole-β-H), 1.77 (s, 12 H, CH3), 1.43 (s, 18 H, CH3); 13C-NMR (CDCl3, 100 MHz) 
[ppm], δ 29.3, 31.4, 35.9, 36.0, 105.9, 107.3, 111.9, 116.9, 118.5, 121.4, 138.0, 140.6, 
142.9, 156.2; MS (HR-ESI) Calcd. for C50H53N16 (M+H+) 877.4639; Found 877.4644 
(M+H+). 
 
2.4.3 Conformation analysis for macrocycle 2.1 in CDCl3 
The 1H NMR spectrum of 2.1 recorded in CDCl3 at 300 K showed a set of high 
resolution signals, which is consistent with the macrocycle either having a fixed 
conformation with high symmetry or a flexible structure and being involved in a fast 
reversible equilibrium process (Figure 2.5).16-19 The 2D NOESY NMR spectrum, Figure 
2.6, provides evidence that the triazole CH proton (e) has signals that correspond with the 
protons on the benezene subunit (g), (f). 
 
 
Figure 2.5: 1H NMR spectrum of 2.1 recorded in CDCl3 at 300 K. Note: The peak 1.89 
ppm is ascribed to H2O. 
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Figure 2.6: (a) Full view and (b), (c) expanded views of the 2D NOESY NMR spectrum 
of 2.1 recorded in CDCl3 at 300 K. 
Taken in concert, these findings are not consistent with a fixed conformation 
(Figure 2.7a, b) or with the existence of a single non-equilibrating conformation (Figure 
2.7c). Because only one set of signals is seen for hydrogen atoms e, g, f., we propose that 
the compound has a flexible conformation in solution. 
To probe this hypothesis further, variable temperature 1H NMR spectral studies 
were carried out (Figure 2.8). At ambient temperature, the NMR spectra gave defined 
peaks consistent with bond rotation faster than the NMR time scale. As the temperature 
was decreased, peak broadening became evident. We attribute this broadening to slowed 




Figure 2.7: Limiting conformations for the fragments in 2.1 used to interpret the NOESY 




Figure 2.8: Variable temperature 1H NMR spectrum of macrocycle 2.1 in CDCl3. 
 
2.4.4 UV-Vis Binding Studies 
UV-Vis Spectroscopic Titrations 
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Stock solutions of the host molecule being studied were made up in chloroform 
with the final concentrations being 1×10-5 M. Stock solutions of the guest in question 
were prepared by dissolving 100 - 300 equivalents of the tetrabutylammonium (TBA) 
salts of the anions under study in 5 mL stock solutions of the host. Making up the anion 
source solutions in this way allowed the binding studies to be carried out without having 
to make mathematical corrections to account for changes in host concentration as the 
result of dilution effects. 
The general procedure for the UV-Vis binding studies involved making sequential 
additions of titrant (anionic guest) using Hamilton pipettes to a 3 mL aliquot of the host 
stock solution in a spectrometric cell. The data was then collated and combined to 
produce plots that showed the changes in host spectral features as a function of guest 
concentration. 
 
Job Plot Construction: 
Stock solutions of the macrocycle (1.0 × 10–5 M) and TBA3HP2O7 (1.0 × 10–5 M) 
were prepared separately in CHCl3. For the other anions, stock solutions of the 
macrocycle (5.0 × 10–5 M) and the tetrabutylammonium anion salts (5.0 × 10–5 M) were 
prepared separately in CHCl3. The UV-Vis spectrum was taken for each of 11 different 
solutions containing a total of 3.0 mL of the macrocycle 2.1 and tetrabutylammonium salt 
in the following ratios: 3.0:0, 2.7:0.3, 2.4:0.6, 2.1:0.9, 1.8:1.2, 1.5:1.5, 1.2:1.8, 0.9:2.1, 
0.6:2.4, 0.3:2.7 and 0:3.0. Job’s plots were constructed by plotting Aobs–AM–Aanion against 





Calculations of Equilibrium Constants, Ka 
Upon addition of tetrabutylammonium salts, the UV spectra changed gradually. 
These changes were ascribed to anion binding, with the corresponding association 
constants (Ka) being determined by nonlinear curve fitting of the curves obtained by 
plotting the absorbance changes at a λ value where the spectral change was maximal (
ΔA) against the concentration of the tetrabutylammonium anion salt added, [X-]. The 
data was fitted to the equation, 
ΔA = A·{([2.1] + [X-] + (1/Ka))–{([2.1] + [X-] + (1/Ka))2–(4·[2.1]·[X-])}1/2} / (2·
[2.1]) 
where, the one unknown parameter is Ka, the value of the association constant; this value 
was obtained by the fit to the data with good fits (e.g., Rˆ2 ≥0.99) being obtained 
unless noted otherwise. 
 
 
Figure 2.9: (a) UV-vis spectra of 2.1 (1.00 × 10-5 M) in chloroform with increasing ((n-
Bu)4N)3HP2O7 (0 ~ 3.0 × 10-5 M). (b) Job plot for the interaction between 
host 2.1 and ((n-Bu)4N)3HP2O7 in chloroform with [host + guest] = 1.00 × 
10-5 M. A maximum value at 0.5 is seen; this is consistent with a 1:1 (host : 
guest) binding stoichiometry. 
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Figure 2.10: (a) UV-vis spectra of 2.1 (1.00 × 10-5 M) in chloroform with increasing (n-
Bu)4NH2PO4 (0 ~ 5.0 × 10-5 M). (b) Job plot for the interaction between host 
2.1 and (n-Bu)4NH2PO4 in chloroform with [host + guest] = 5.00 × 10-5 M. A 




Figure 2.11: (a) UV-vis spectra of 2.1 (1.00 × 10-5 M) in chloroform with increasing (n-
Bu)4NHSO4 (0 ~ 3.0 × 10-5 M). (b) Job plot for the interaction between host 
2.1 and (n-Bu)4NHSO4 in chloroform with [host + guest] = 5.00 × 10-5 M. A 




Figure 2.12: (a) UV-vis spectra of 2.1 (1.00 × 10-5 M) in chloroform with increasing (n-
Bu)4NCl (0 ~ 8.0 × 10-4 M). (b) UV-vis spectra of 2.1 (1.00 × 10-5 M) in 



















Figure 2.13: (a) Variations in the absorbance at 340 nm (▪) of a solution of receptor 2.1 
(1.00 × 10-5 M) in CHCl3 as a function of (TBA)3HP2O7 concentration (0 ~ 
3.0 × 10-5 M) at 300 K. (b) Variations in absorbance (▪) at 340 nm of a 
solution of receptor 2.1 (1.00 × 10-5 M) in CHCl3 as a function of 
TBAH2PO4 concentration (0 ~ 5.0 × 10-5 M) at 300 K. (c) Variations in 
absorbance (▪) at 340 nm of a solution of receptor 2.1 (1.00 × 10-5 M) in 
CHCl3 as a function of TBAHSO4 concentration (0 ~ 3.0 × 10-5 M) at 300 K. 
(d) Variations in absorbance (▪) at 300 nm of a solution of receptor 2.1 (1.00 
× 10-5 M) in CHCl3 as a function of TBACl concentration (0 ~ 8.0 × 10-4 M) 
at 300 K. (e) Variations in absorbance (▪) at 330 nm of a solution of receptor 
2.1 (1.00 × 10-5 M) in CHCl3 as a function of TBABr concentration (0 ~1.25 




2.4.5 NMR Anion Recognition Study: 
Solutions of receptor 2.1 (5 mM, CDCl3, 300 K) were titrated by adding known 
quantities of a concentrated solution of various tetrabutylammonium anion salts. The 
anion solutions used to effect the titration contained the receptors at the same 
concentration as the receptor solutions into which they were being titrated so as to 
obviate the need to account for dilution effects during the titrations. 
 
Table 2.1:  Chemical shift changes for selected signals of 2.1 seen in the presence of 10 
equiv. TBA3HP2O7, TBAH2PO4, TBAHSO4, TBACl and TBABr. The 
changes are relative to what is seen for pure 2.1. 
 ∆ / ppm 
1
H a b c d e f 
2.1·TBA3HP2O7 5.094 1.792 1.211 0.277 0.088 -0.296 
2.1·TBAH2PO4 2.196 2.114 1.664 0.342 0.189 -0.124 
2.1·TBAHSO4 1.265 1.125 0.409 0.299 0.185 -0.111 
2.1·TBACl 3.172 1.072 -0.050 -0.107 0.049 -0.285 
2.1·TBABr 2.102 1.029 -0.068 -0.026 0.075 -0.227 
 
The pyrrole NH hydrogen signal (a), the triazole hydrogen signal (b) and the endocyclic 
hydrogen atom of the N1-linked phenyl unit (c) all undergo significant shifts when anions 
are added (Table 2.1); this is consistent with the proposition put forward in the text, 






Figure 2.14: 1H NMR spectrum of macrocycle 2.1 and 0.5, 1.0, 2.0, 5.0, 10.0 equiv. 
(TBA)3HP2O7 recorded in CDCl3 at 300 K. 
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Figure 2.15: 1H NMR spectrum of macrocycle 2.1 and 0.5, 1.0, 2.0, 5.0, 10.0 equiv. of 




Figure 2.16: 1H NMR spectrum of macrocycle 2.1 and 0.5, 1.0, 2.0, 5.0, 10.0 equiv. of 
TBAHSO4 recorded in CDCl3 at 300 K. 
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Figure 2.17: 1H NMR spectrum of macrocycle 2.1 and 0.5, 1.0, 2.0, 5.0, 10.0 equiv. of 
TBACl recorded in CDCl3 at 300 K. 
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Figure 2.18: 1H NMR spectrum of macrocycle 2.1 and 0.5, 1.0, 2.0, 5.0, 10.0 equiv. of 









2.4.6 Details of High Resolution ESI Mass Spectrometric Study: 
Table 2.2:  ESI High Resolution Mass Spectra Study for Complexes Stabilized by 
Receptor 2.1. 


































Figure 2.19: ESI high resolution mass spectrum of samples containing, respectively, 1 
molar equiv. of (TBA)3HP2O7 (a), TBAH2PO4 (b), TBAHSO4 (c), TBACl 
(d), TBABr (e) and host 2.1. 
 
 
2.4.7 Details of Electronic Structure Calculations 
These studies were carried out by our collaborator, Dr. Benjamin Hay, and are 
included here for the benefit of the reader, even though they are not part of the author’s 
dissertation work. 
Binding energy, ∆E=E(complex)–E(chloride)–E(donor) values were calculated at 
the MP2/aug-cc-pVDZ level of theory with NWChem.20 Cartesian coordinates and 
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absolute energies for geometries optimized with NWChem at the MP2/aug-cc-pVDZ 




   
 







Energy –209.5630199 hartree 
10 
  C    1.131607   -0.714996    0.029633 
  C   -0.200928   -1.132996   -0.005264 
  C    1.131607    0.714996    0.029633 
  C   -0.200928    1.132996   -0.005264 
  N   -0.987671    0.000000   -0.025864 
 44 
  H    2.000305   -1.369995    0.052383 
  H   -0.641785   -2.127000   -0.016815 
  H    2.000305    1.369995    0.052383 
  H   -0.641785    2.127000   -0.016815 
  H   -2.000305    0.000000   -0.052383 
 




N---Cl = 3.073 Å ; N-H---Cl = 2.020 Å 
Energy –669.3216376 hartree 
11 
  C    2.157608   -0.714996   -0.226776 
  C    0.819977   -1.121994   -0.086182 
  C    2.157608    0.714996   -0.226776 
  C    0.819977    1.121994   -0.086182 
  N    0.035309    0.000000   -0.003708 
  H    3.020859   -1.375000   -0.317505 
  H    0.374435   -2.112991   -0.039352 
  H    3.020859    1.375000   -0.317505 
 45 
  H    0.374435    2.112991   -0.039352 
  H   -1.011917    0.000000    0.106354 







Energy –231.5398383 hartree 
12 
  C   -0.363998    1.359985    0.000000 
  C   -1.359985    0.363998    0.000000 
  C   -0.995987   -0.995987    0.000000 
  C    0.363998   -1.359985    0.000000 
  C    1.359985   -0.363998    0.000000 
  C    0.995987    0.995987    0.000000 
  H   -0.647995    2.416992    0.000000 
  H   -2.416992    0.647995    0.000000 
  H   -1.768997   -1.768997    0.000000 
  H    0.647995   -2.416992    0.000000 
 46 
  H    2.416992   -0.647995    0.000000 
  H    1.768997    1.768997    0.000000 
 
 




C---Cl = 3.491 Å; C-H---Cl = 2.388 Å 
Energy –691.2765323 hartree 
13 
  Cl    3.699539    0.000000    0.291153 
  C   -1.901123   -1.217987   -0.149612 
  C   -0.496460   -1.212997   -0.039078 
  C    0.219315    0.000000    0.017258 
  C   -0.496460    1.212997   -0.039078 
  C   -1.901123    1.217987   -0.149612 
  C   -2.607941    0.000000   -0.205246 
  H    1.318909    0.000000    0.103790 
  H   -2.447433   -2.168000   -0.192612 
  H    0.055832   -2.157990    0.004395 
  H    0.055832    2.157990    0.004395 
 47 
  H   -2.447433    2.168000   -0.192612 







Energy -241.5979766 hartree 
8 
  C   -0.402557    0.546936    0.000000 
  C   -0.621628   -0.829620    0.000000 
  N    0.956009    0.644669    0.000000 
  N    1.561417   -0.566986    0.000000 
  N    0.583588   -1.478409    0.000000 
  H   -1.060898    1.410828    0.000000 
  H   -1.561432   -1.375351    0.000000 
  H    1.534958    1.478424    0.000000 
 
1,2,3-triazole chloride complex, bound to N-H  





N---Cl = 2.987 Å; N-H---Cl = 1.950 Å 
Energy -701.3667612 hartree 
9 
  C   -0.722931    0.623535    0.000000 
  C   -2.034409    0.142654    0.000000 
  N    0.041397   -0.496643    0.000000 
  N   -0.713638   -1.614517    0.000000 
  N   -2.006256   -1.225784    0.000000 
  H   -0.277451    1.614517    0.000000 
  H   -2.974121    0.691391    0.000000 
  H    1.109436   -0.496643    0.000000 
 Cl    2.974121    0.072388    0.000000 
 
 
1,2,3-triazole chloride complex, bound to C-H  





C---Cl = 3.349 Å; C-H---Cl = 2.244 Å 
Energy –701.3509268 hartree 
9 
  C   -0.553238    0.031158    0.000000 
  C   -1.566360    0.991150    0.000000 
  N   -1.264648   -1.130493    0.000000 
  N   -2.606537   -0.947678    0.000000 
  N   -2.795837    0.382050    0.000000 
  H    0.551865    0.031174    0.000000 
  H   -1.473282    2.074097    0.000000 
  H   -0.891617   -2.074097    0.000000 




2.4.8 Crystallographic Data (CIF) 
Crystals used in this study were obtained by the author. They were in the form of 
multiply intergrown, colorless needles in the case of macrocycle 2.1·4CH3OH·H2O, and 
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yellow prisms in the cases of the complex 2.1·TBA3HP2O7·3H2O. Diffraction grade 
crystals of macrocycle 2.1·4CH3OH·H2O were obtained by slow evaporation from 
solution using a CHCl3 / CH3OH mixture. Crystals of the complex 2.1·TBA3HP2O7·3H2O 
were obtained by slow evaporation from solution using CHCl3. The data crystals were cut 
from a cluster of crystals and had the approximate dimensions given in Table 2.3. The 
data were collected by the author on a Rigaku Saturn CCD diffractometer using a 
graphite monochromator with MoK α radiation (λ = 0.71075 Ǻ). The data were 
collected using ω-scans with a scan range of 1˚ at low temperature shows using an 
Oxford Cryostream low temperature device (Table 2.3). Data reduction was performed 
using DENZO-SMN.21 The structures were solved by Dr. Xiaoping Yang via direct 
methods using SIR9722 and refined by full-matrix least-squares on F2 with anisotropic 
displacement parameters for the non-H atoms using SHELXL-97.23 The hydrogen atoms 
were calculated in ideal positions with isotropic displacement parameters set to 1.2 × Ueq 
of the attached atom (1.5 × Ueq for methyl hydrogen atoms). 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized. Definitions used for calculating 
R(F), Rw(F2) and the goodness of fit, S, are given below.24 Neutral atom scattering 
factors and values used to calculate the linear absorption coefficient are from the 
International Tables for X-ray Crystallography (1992).25 All ellipsoid figures were 
generated using SHELXTL/PC.26 Tables of positional and thermal parameters, bond 
lengths and angles, torsion angles, figures and lists of observed and calculated structure 
factors are located in the cif documents available from the Cambridge Crystallographic 
Centre via quoting ref. numbers 786883 and 786884. These documents also contain 
details of crystal data, data collection and structure refinement. 
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Table 2.3:  X-ray crystallographic data comparison of macrocycle 2.1·4CH3OH·H2O  





CCDC No. 786884 786883 
empirical formula C54N16O5H70 C98N19P2O10H167 
Fw 1021.24 1826.39 
crystal size (mm
3
) 0.31× 0.13 × 0.02 0.37× 0.11 × 0.02 
Crystal system Monoclinic Monoclinic 
Space group P2/c P2(1)/c 
a [Ǻ] 18.799(4) 17.507(4) 
b [Ǻ] 7.4924(15) 39.237(8) 
c [Ǻ] 23.685(5) 24.684(5) 
α [deg] 90.00 90.00 
β [deg] 125.38(3) 131.52(3) 
γ [deg] 90.00 90.00 
V / [Ǻ
3
] 2719.9(9) 12694(4) 
d / [g/cm
3
] 1.247 0.956 
Z 2 4 
T [K] 223(2) 113(1) 
R1, wR2  I > 2ό(I) 0.0929, 0.2083 0.0979, 0.2669 
R1, wR2 (all data) 0.1945, 0.2700 0.1368, 0.2973 




Figure 2.20: Views of the single crystal X-ray structure of 2.1·4CH3OH·H2O. All solvent 
molecules have been omitted for clarity and thermal ellipsoids drawn at the 
25% probability level. Symmetry operator (-x, 1-y, -z) generates equivalent 
atoms marked with “A”. a, Top view and b, side view showing the near 
planar conformation of 2.1. Selected distances [Ǻ]: a = 2.558, b = 2.744, c = 
2.601, d = 3.056. This leads us to suggest that intramolecular H-bonding 
interactions on the exterior of the ring help stabilize the observed planar 







Figure 2.21: Views of the single crystal X-ray structure of 2.1·TBA3HP2O7·3H2O. All 
solvent molecules and TBA cations have been omitted for clarity and 
thermal ellipsoids drawn at the 25% probability level. a, Top view and b, c 
side view showing that the pyrophosphate anion is in a space filling 
representation. Selected distances [Å]: a = 1.905, b = 2.324, c = 3.870. This 
confirms that pyrrole NH and triazole CH protons are involved in hydrogen 
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Chapter 3: A Pyrrole-based Triazolium-phane with NH and Cationic 
CH Donor Groups as a Receptor for Tetrahedral Oxyanions that 
Functions in Polar Media 
 
3.1 INTRODUCTION 
One goal of supramolecular chemistry1 is to create synthetic receptors that have 
both high affinity and high selectivity for biologically and environmentally important 
anionic species.2 Anions are ubiquitous in the natural world and critical to the 
maintenance of life as we know it.3 Pyrophosphate, for instance, is a byproduct of ATP 
hydrolysis under cellular conditions.4 It is involved in DNA polymerase–catalyzed DNA 
replication5 and its detection pyrophosphate could provide for real–time DNA 
sequencing.6 Its analogue, inorganic phosphate, has physiological relevance in biological 
energy storage and signal transduction, in addition to being a structural component in 
teeth and bones.7 Sulfate, because of its low solubility (typically ca. 1%) in borosilicate 
glass, has been identified as problematic in the vitrification of radioactive waste.8 Not 
surprisingly, therefore, considerable effort has been devoted to the design and synthesis 
of receptors capable of recognizing and detecting these tetrahedral oxyanions.2 Systems 
incorporating neutral or cationic NH hydrogen bond donor groups (e.g., pyrrole, urea, 
amide, ammonium, and guanidinium)9 and neutral or cationic CH hydrogen bond donor 
motifs (e.g., phenyl, triazole, triazolium, and imidazolium)10,16 have been particularly 
effective in this regard. It is noteworthy that positively charged imidazolium derivatives 
can interact with anions through (C–H)+ ···X– type ionic hydrogen bonds, which are 
generally stronger than the corresponding hydrogen–bonding interactions stabilized by 
neutral pyrrole and urea moieties.10(f) Recently, 1,2,3–triazolium motifs with cationic CH 
hydrogen bond donor groups have garnered attention for their potential use in transition 
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metal–based catalysis11 and organocatalysis.12 However, they have yet to be exploited 
extensively in anion recognition chemistry.10(b),13 In fact, we are aware of only three 
reports of anion receptors containing 1,2,3–triazolium subunits. None of the systems in 
question was found to be effective in the presence of water and only one, an open-chain 
threading element reported by Beer and coworkers,10(b) has been structurally characterized 
in the form of its anion complex (chloride). Here, we report a new synthetic anion 
receptor, 3.14+, that combines both pyrrole and triazolium anion recognition motifs within 
one macrocyclic framework. It exhibits high selectivity and affinity for tetrahedral 
oxyanions and functions effectively in mixed organic-aqueous media. Based on a 
combination of theoretical, solution phase, and single crystal X-ray diffraction analyses, 
we propose that oxyanion recognition is stabilized via a combination of C–H··· and N–
H···anion hydrogen bonding and electrostatic interactions, both in solution and in the 
solid state. We also conclude that in highly polar media, such as methanol, phenyl CH-
anion interactions play a greater stabilizing role in anion binding than do triazolium 
(CH)+– anion interactions. 
The paucity of attention devoted to 1,2,3–triazolium-based anion recognition 
systems stands in marked contrast to what is true for neutral triazoles. These latter motifs, 
first pioneered for anion recognition by Flood and coworkers, have provided an important 
new submit for anion recognition.10(d) One reason triazole systems are attractive is because 
they can be accessed via so-called “click” chemistry, specifically the copper(I)–catalyzed 
azide alkyne 1,3–dipolar cycloaddition (CuAAC) reaction.14,15 They can also be readily 
incorporated into a variety of cyclic and acyclic structures. One further appeal of triazoles 
is that, at least in principle, they can be converted to the corresponding triazolium salts by 
simple alkylation.10(b) With this consideration in mind we sought to prepare the 
tetracationic macrocycle 3.14+ by subjecting the corresponding triazole system 3.2 to 
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methylation (Scheme 3.1). As detailed below, this strategy proved easy to implement and 
gave rise to an anion receptor 3.14+ that contains four triazolium subunits. A notable 
feature of this new system is that it contains three different types of putative hydrogen 
bond donor groups (benzene CH, triazolium CH, and pyrrole NH). Thus, an ancillary 
objective associated with the present study was an assessment of the relative importance 
of the resulting subunit-anion interactions. 
 
3.2 RESULTS AND DISCUSSIONS 
The synthesis of calix[2]1,3–bis(pyrro–2–yl)(1,4)–1,2,3–triazolo–phane 3.2 
(Scheme 3.1) was accomplished in three steps as detailed in chapter 2. Briefly, the key 
fragment 1,3–bis(pyrro–2–yl)(1,4)–1,2,3–triazolo–benzene was prepared under standard 
click conditions,14 followed by removal of the t–BOC protecting group;17 it was then 
cyclized with acetone to form macrocycle 3.2.18 This was followed by a methylation 
reaction using Meerwein’s salt to give the tetracationic triazolium macrocycle 
tetrafluoroborate salt 3.14+•4BF4– (3.1 = calix[2]1,3–bis(pyrro–2–yl)(1,4)–3–methyl–5H–
1,2,3–triazolium–phane tetrafluoroborate) in 38% yield.10(b) Colorless single crystals of 
3.14+•4BF4– were obtained via vapor diffusion (diethyl ether into a methanol solution of 
the salt). Salt 3.14+•4BF4– was characterized on the basis of its spectroscopic properties 







Scheme 3.1: Synthesis of the tetracationic triazolium macrocycle 3.14+. 
 
 
A single crystal X–ray diffraction analysis of 3.14+•4BF4– revealed a nearly planar 
macrocyclic structure. Two of the BF4– counter anions were found to be located within 
the inner cavity of the tetracationic cyclophane built up from the constituent phenyl, 
pyrrole, and triazolium subunits. The two other counter anions were found to lie outside 
the cage and are not involved in any apparent interaction with the macrocycle, at least in 
the solid state (Figure 3.1). The macrocycle 3.14+•4BF4– is centrosymmetric. The pyrrole 
groups (N4, N4A) and the triazolium motifs (C11, C11A) are twisted out of the plane. 
The hydrogen atoms on the pyrrole NH (N8, N8A), triazolium CH (C20, C20A) and the 
endocyclic hydrogen atoms of the N1–linked phenyl units (C8, C8A) are pointing into the 
center of the ring. Based on the geometric parameters (N- and C-F distances of < 3 Å) 
these endocyclic hydrogen atoms are involved in NH···F, CH···F hydrogen bond 




Figure 3.1: (a) Top and (b) side views of the single crystal X–ray structure of 
3.14+•4BF4–•CH3OH•3H2O. All solvent molecules have been omitted for 
clarity. 
The anion binding properties of 3.14+•4BF4– in solution were analyzed initially 
using UV–Vis spectroscopy. Standard titrations, associated curve fittings,19 and Job plots 
provided support for the proposal that hydrogen pyrophosphate, hydrogen sulfate and 
dihydrogen phosphate anions (all studied as their corresponding tetrabutylammonium 
(TBA) salts) are bound to 3.14+•4BF4– strongly in acetone–H2O solution (2:3; pH = 7.2; 
HEPES buffer) at 300 K (HP2O73–: Ka = (2.49 ± 0.15 ) ×105 M–1; HSO4–: Ka = (3.92 ± 
0.36) ×105 M–1; H2PO4–: Ka = (3.53 ± 0.14) ×104 M–1) and with 1:1 binding 
stoichiometries (Table 3.1). To avoid interference from potential aggregation effects, the 
effective association constants (Ka) were determined at [3.14+•4BF4–] ≤ 50 µM and were 
found to be independent of initial receptor concentration under these conditions. The 
binding isotherms used to determine the Ka values were generated by recording the 
changes in the UV–Vis absorption spectrum as a function of hydrogen sulfate, hydrogen 
pyrophosphate and dihydrogen phosphate concentration (shown for 3.14+•4BF4– in 
Figures 3.2a, b, and c, respectively). Based on Job–plot analyses, which proved consistent 
with a 1:1 binding stoichiometry in the case of these test anions (Figures 3.2d, e, and f, 
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respectively), the data were fit to a 1:1 binding isotherm. Analogous studies were carried 
out in methanol and acetonitrile. The calculated Ka values and binding stoichiometries (as 
inferred from Job plots) for all three solvent systems are summarized in Table 3.1.  
Strictly speaking the Ka values in Table 3.1 are displacement constants and reflect 
any initial interaction between the BF4– counter anions and receptor 3.14+. However, in 
practice the interactions between the BF4– counter anions and the receptor are expected to 
be modest. Further, they will be identical for all anions considered in this study. 
Therefore, we believe that the Ka values tabulated in Table 3.1, which represent lower 
bounds, can be used for the purpose of inter–analyte comparisons. 
From an inspection of Table 3.1, the effect of solvent on the anion binding 
behavior of receptor 3.14+•4BF4– can be inferred. While in acetonitrile a general lack of 
anion selectivity is seen (the binding constants for various test anions range between 105 
and 106 M–1), in methanol, considerable selectivity for tetrahedral oxyanions is seen 
relative to other typical anionic analytes (e.g., acetate, nitrate, chloride and bromide; all 
studied as the corresponding TBA salts). This selectivity is maintained and even 
enhanced in acetone–H2O (2:3; pH = 7.2; HEPES buffer). In fact, under these latter, 
mixed aqueous solvent conditions, receptor 3.14+ (as its tetrakis BF4– salt) binds the 
tetrahedral oxyanions hydrogen sulfate, hydrogen pyrophosphate and dihydrogen 
phosphate anions with affinities of 104–105 M–1. However, it displays no appreciable 
affinity for any of the other test anions.  
The combination of high affinity and selectivity for tetrahedral oxyanions in 
mixed aqueous medium is noteworthy. While systems that bind tetrahedral oxyanions in 
organic media based on hydrogen–bonding interaction are well known, there are few that 
operate in the presence of large quantities of water. In prior work, Kubik and coworkers 
demonstrated that synthetic cyclopeptides containing alternating aromatic and L–proline 
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residues could bind inorganic anions, such as halides and sulfate, efficiently in 80% H2O–
CH3OH, although little appreciable selectivity for the sulfate anion was observed.20 In 
separate work, Delgado and coworkers demonstrated that protonated hexaamine–cage 
receptors could efficiently interact with tetrahedral oxyanions in 50% H2O–CH3OH at 
low pH.21 In earlier work, Lehn and coworkers reported that guanidinium–containing 
macrocycles could be used for the recognition of phosphate in water.22 However, these 
latter receptors formed less stable anion complexes than the corresponding protonated 
ammonium–based receptors. There thus remains a need for new receptors that are 

















Table 3.1:  Binding Affinities of Different Anions to Receptor 3.14+•4BF4– in Three 
Different Solvent Systemsa  
Guest 
CH3CNb CH3OHb 
acetone –H2O (2:3)b 











Ka = ( 9.88 ± 1.18) 
×106 M–1 
1:1 
Ka = ( 1.60 ± 0.22) 
×107 M–1 
1:1 
Ka = ( 3.92 ± 0.36) 
×105 M–1 
HP2O73– 1:1 
Ka = ( 9.89 ± 1.06 ) 
×105 M–1 
1:1 
Ka = ( 1.17 ± 0.17 ) 
×107 M–1 
1:1 
Ka = ( 2.49 ± 0.15 ) 
×105 M–1 
H2PO4– 1:2 
Ka.1 = ( 6.44 ± 0.16) 
×103 M–1 
Ka.2 = ( 1.03 ± 0.04) 
×105 M–1 
1:1 
Ka = ( 1.73 ± 0.15) 
×106 M–1 
1:1 
Ka = ( 3.53 ± 0.14) 
×104 M–1 
CH3COO– 1:1 
Ka = ( 2.25 ± 0.14) 
×106 M–1 
1:1 




Ka = ( 5.99 ± 0.61) 
×105 M–1 
1:1 




Ka = ( 4.48 ± 0.53) 
×106 M–1 
1:1 




Ka = ( 2.46 ± 0.25) 
×106 M–1 
1:1 




aDetermined by UV–Vis titrations carried out at 300 K using the tetrabutylammonium 
(TBA) salts of the indicated anions. bFor studies in CH3CN and CH3OH, [3.14+•4BF4–] = 
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1.00 × 10–5 M; for studies in acetone–H2O (2:3; pH = 7.2; HEPES buffer), [3.14+•4BF4–] = 




Figure 3.2: Variations in absorbance (▪) at 380nm of a solution of receptor 3.14+•4BF4– 
(5.00 × 10–5 M) in acetone–H2O (2:3) (PH = 7.2 in HEPES buffer) as a 
function of the concentration in TBAHSO4 (0–6.0 × 10–5 M) (a), 
TBA3HP2O7 (0–8.0 × 10–5 M) (b) and TBAH2PO4 (0–2.5 × 10–4 M) (c) at 
300 K. The Job–plot for the complexation between 3.14+•4BF4– and 
TBAHSO4 (d), (TBA)3HP2O7 (e) and TBAH2PO4 (f) in acetone–H2O (2:3) 
(PH = 7.2 in HEPES buffer) at 300 K. [host] + [guest] = 5.00 × 10–5 M. A 
maximum value at 0.5 is observed; this is consistent with a 1:1 (host : guest) 
binding stoichiometry. 
 
To understand the solvent dependence noted above and to allow a comparison of 
the intrinsic hydrogen bonding ability of the donor groups present in receptor 3.14+, ∆G 
values for the formation of the representative complexes between the Cl– anion and the 
simple donors shown in Figure 3.3 were computed in the gas phase under vacuum 
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conditions (cf. Experimental Section for Cartesian coordinates and absolute energies).23 
Similar calculations were carried out in several pure solvents (e.g., CHCl3, acetone, 
CH3CN, CH3OH, and H2O).24 In prior studies, comparison of hydrogen bonding 
interactions between C–H and N–H donor groups with different anion shapes (chloride, 
nitrate, perchlorate) established that similar binding energy trends are observed for this 
group of monovalent anions.10(e),32 Therefore, we have used the chloride as a 
representative anion, primarily because the system is small and the number of possible 
minima is limited. The results, summarized in Table 3.2, reveal that although the 
formation of the triazolium complex is by far the most favorable in vacuum, the binding 
affinity (as measured by ∆G) decreases dramatically for the corresponding process in 
CHCl3. This interaction becomes even less favorable in the case of more polar solvents. 
In the case of higher dielectric constant solvents, i.e., ε > 20 (acetone, CH3CN, CH3OH, 
and H2O), the calculated ∆G values lead to the inference that the driving force for 
hydrogen bond formation decreases in the following order: pyrrole > triazole > benzene > 
triazolium cation. The driving force for forming complexes between the Cl– anion and 
three putative hydrogen bonding donors present in the macrocycle 3.14+•4BF4– (pyrrole 
N–H, benzene C–H and triazolium C–H) all decrease on passing from acetonitrile to 
methanol (Table 3.2). Such a conclusion is fully consistent with the results of the UV–Vis 
experimental studies discussed above: In case of both theory and experiment, the binding 
constants for interactions with monoanions were found to become smaller as the polarity 
of the medium increased (e.g., on moving from acetonitrile to methanol).25 However, for 
tetrahedral oxyanions, the binding constants proved to be both inherently high and rather 
independent of solvent polarity. This could reflect the greater size and complexity of 
these latter ions, features that would tend to augment the importance of specific hydrogen 
bonding interactions relative to competitive anion solvation. Independent of rationale, it 
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is important to underscore that the theoretical analyses lead to the perhaps 
counterintuitive conclusion that in methanol the benzene CH-anion hydrogen bond 
interactions are more important than the corresponding imidazolium CH-anion 
interactions. Experimental support for this conclusion was obtained from detailed 1H 
NMR analyses as detailed below. 
 
 
Figure 3.3: Representative complexes that provide examples of the hydrogen bonding 
interactions present in the macrocycles. 
 
Table 3.2:  Influence of solvent on calculated ∆G values (kcal/mol) for the formation of 
hydrogen-bonded complexes between Cl– and representative simple donors 
(Figure 3.3) 
donor solvent 
vacuum CHCl3 Acetone CH3CN CH3OH H2O 
triazolium C–H –89.2 –4.0 11.5 14.0 19.5 20.7 
pyrrole N–H –15.6 –3.0 –1.9 –1.3 3.9 4.1 
triazole C–H –12.4 2.5 4.8 5.4 8.7 8.6 
benzene C–H –2.4 5.7 6.1 6.4 8.9 8.6 
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The host-guest interactions between receptor 3.14+•4BF4– and representative 
tetrahedral oxyanions were further analyzed by 1H NMR spectroscopy. Proton NMR 
titrations were carried out in deuterated methanol using the respective TBA salts. 
Unfortunately, solubility considerations precluded analogous titrations being carried out 
in either CD3CN or 60% D2O/40% acetone–d6. The titrations were performed as follows: 
A solution of receptor 3.14+•4BF4– (4 mM, CD3OD) was titrated with up to 10 equiv. of 
the TBA anion salt of choice. A representative titration is shown in Figure 3.4 for 
(TBA)3HP2O7. It is worth noting that the pyrrole NH protons were generally not visible 
under the conditions of these titrations, presumably as the result of fast exchange with the 
CD3OD solvent. As a general rule, and as can be seen by inspection of Figure 3.4, little 
shift in the signals for the triazolium CH protons was typically seen. In contrast, the 
resonances corresponding to the endocyclic hydrogen atoms of the N1–linked phenyl unit 
were observed to shift downfield by 1.01 ppm, 0.48 ppm, and 0.45 ppm upon the addition 
of 5 equiv. of (TBA)3HP2O7, TBAH2PO4 and TBAHSO4, respectively (cf. Experimental 
Section). Such differing shift behavior is consistent with the differences in the intrinsic 
strength of the various H–bond donor groups inferred from the electronic structure 
calculations carried out in methanol using the chloride anion. The calculated ∆G values 
of the interaction of chloride with benzene C–H and triazolium C–H complexes are 8.9 
and 19.5 kcal/mol in methanol (Table 3.2). This combination of theory and experiment 
provides support for the conclusion that the anion interactions stabilized by a benzene C–
H hydrogen bond is stronger than that stabilized by a triazolium C–H hydrogen bond in 
methanol.  
Proton NMR titrations were also carried out in deuterated methanol using receptor 
3.14+•4BF4– and both monoanionic and trigonal planar anionic salts, such as TBAOAc, 
TBANO3, TBACl, and TBABr (cf. Experimental Section). The hydrogen signals for the 
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endocyclic hydrogen atoms of the N1–linked phenyl unit shifted slightly during the 
associated NMR titrations. On the other hand, little observable shift was seen for the 
triazolium CH signal. Such findings are consistent with the relative contribution of these 
two CH donor motifs inferred above. Moreover, they provide support for the conclusions 
drawn from the UV–Vis titration experiments, namely that in methanol receptor 
3.14+•4BF4–interacts with tetrahedral oxyanions much more strongly than it does with 




Figure 3.4: 1H NMR spectra (aromatic region) of receptor 3.14+•4BF4– (4 mM) recorded 




Further support for the proposal that receptor 3.14+ is able to interact with the 
pyrophosphate and phosphate anions came from single crystal X-ray diffractions 
analyses. For instance, crystallization of mixture consisting of the starting salt 3.14+•4BF4– 
and (TBA)3HP2O7 in methanol via the slow diffusion of diethyl ether afforded crystals of 
3.14+•HP2O73–•BF4–. The resulting structure confirmed that in this mixed salt the 
receptor/pyrophosphate anion ratio was 1:1 (Figure 3.5). It also revealed that the 
macrocycle adopts a folded conformation, forming a clip–like slot into which the 
pyrophosphate anion inserts. The BF4– anion resides outside of the cavity. All the pyrrole 
NH, triazolium CH and endocyclic benzene CH protons point into the center of the ring 
and are involved in hydrogen bonding interactions with the bound pyrophosphate guest, 
as inferred from bond distances (pyrrole NH···O approx. 1.9 Å, triazolium CH···O 
approx. 2.0 Å, benzene CH···O approx. 3.4 Å). The resulting conformation thus stands in 
contrast to what is seen in the case of the starting host, 3.14+•4BF4–. 
 
 
Figure 3.5: (a) Top and (b) side views of a single–crystal X–ray diffraction structure of 
3.14+•HP2O73–•BF4– in which the pyrophosphate anion is in a space filling 
representation and the tetrafluoroborate anion resides outside of the ring.  
The addition of tetrabutylammonium dihydrogen phosphate (TBAH2PO4) to a 
methanolic solution of 3.14+•4BF4– and subjecting it to crystallization via diffusion of 
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diethyl ether resulted in the isolation of single crystals of a complex with a formal 
stoichiometry 2(3.14+)•2H2PO4–•6BF4–. The resulting structure is shown in Figure 3.6. It 
includes two complex salts; the first of these consists of 3.14+•2H2PO4–•2BF4–, whereas 
the latter consists of 3.14+•4BF4– (Figure 3.6a). The structure of 3.14+•2H2PO4–•2BF4– 
displays the same folded conformation as observed in the case of 3.14+•HP2O73–•BF4–, 
with two phosphate anions located in the center of the ring (Figure 3.6b, c). However, in 
contrast to this latter structure in 3.14+•2H2PO4–•2BF4–, the pyrrole NH (N4, N5) and 
triazolium CH (C11, C25) protons point away from the center of the ring. N–H···O and 
C–H···O hydrogen bonds are formed between the macrocycle and phosphate anions (the 
pyrrole NH···O distance is approx. 2.1 Å; the triazolium CH···O distance is approx. 2.8 
Å; the endocyclic benzene CH···O distance is approx. 2.6 Å).  
Another 3.14+•4BF4– salt within the mixed complex (Figure 3.6d, e) shows a 
similar planar conformation as the structure of 3.14+•4BF4– shown in Figure 3.1. However, 
in the present instance all the pyrrole groups, triazolium motifs and benzene rings are 
twisted out of the mean macrocyclic plane. As a result, the associated NH, triazolium CH 
and endocyclic benzene CH protons point away from the center of the ring. Two BF4– 
anions are found to be located closely above and below the plane of the ring, presumably 
as the result of hydrogen bond interactions with the pyrrole NH (N20, N20A) and 
triazolium CH (C62, C62A) protons. The relevant pyrrole NH···F and triazolium CH···F 
distances are ca. 2.1 Å and 2.7 Å, respectively). Another pair of BF4– ions is located 






Figure 3.6:  (a) A single–crystal X–ray diffraction structure of 2(3.14+)•2H2PO4–•6BF4– 
which contains two parts: one composed of 3.14+•2H2PO4–•2BF4– and the 
other composed of the free receptor 3.14+•4BF4–. (b) Top and (c) side views 
of a single–crystal X–ray diffraction structure of 3.14+•2H2PO4–•2BF4– with 
two phosphate anions located in the center of the ring, which is part of the 
structure of 2(3.14+)•2H2PO4–•6BF4–. (d) Top and (e) side views of a single–
crystal X–ray diffraction structure of 3.14+•4BF4–, which is part of the 
structure of 2(3.14+)•2H2PO4–•6BF4–. 
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In summary, the pyrrole–based triazolium–phane 3.14+•4BF4– has been prepared 
via the tetraalkylation of a macrocycle originally prepared via click chemistry. It displays 
a high selectivity for tetrahedral oxyanions relative to various test monoanions and 
trigonal planar anions in mixed polar organic–aqueous solvent media. This selectivity is 
solvent dependent and is less pronounced in acetonitrile. Single crystal X-ray diffraction 
analyses of the mixed salts 3.14+•HP2O73–•BF4– and 2(3.14+)•2H2PO4–•6BF4– provided 
support for the notion that receptor 3.14+ can bind the pyrophosphate and phosphate 
anions. The present results thus serve to underscore the benefits of combining various 
hydrogen bond donor motifs within a single receptor to achieve the recognition of 
particular anionic substrates. The fact that the motifs in question are contained within a 
relatively rigid macrocyclic framework in the case of 3.14+ allowed for a direct 
comparison of the relative importance of NH–, CH–, and (CH)+–anion interactions. The 
associated results, both experimental and theoretical, provided support for the perhaps 
unexpected conclusion that (CH)+– anion interactions are less important in an energetic 
sense than neutral CH–anion interactions in methanol. These findings have important 
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implications for future receptor design, particularly systems designed to recognize anions 
in highly polar organic media or aqueous environments. 
 
3.4 EXPERIMENTAL SECTION 
3.4.1 General Procedures 
All reagents and starting materials were obtained from commercial suppliers and used as 
received unless otherwise noted. Column chromatography was performed on silica gel 
(40-63 μm, Silicycle, Canada) and Alumina N (50-200 μm, Dynamic Adsorbents Inc., 
USA). Nuclear magnetic resonance (NMR) spectra were recorded on Varian Mercury 
400, Varian Inova 500, and Varian DirectDrive 600 instruments. UV-Vis spectra were 
recorded on a Cary 5000 UV-Vis-NIR Spectrophotometer. Low resolution ESI mass 
spectra were measured using either a Finnigan LCQ Quadrupole Ion Trap Mass 
Spectrometer or a Thermo LTQ-XL linear Ion Trap Mass Spectrometer. High resolution 
ESI mass spectra were obtained on an Ion Spec Fourier Transform mass spectrometer 
(9.4 T). PH value was detected by an Orion Model 720A pH meter. Unless otherwise 
noted, a pH of 7.2 was recorded for the mixed solvent mixture (5 mM HEPES buffer in 
60% water/acetone) used to study the macrocycle (3.14+·4BF4-; 5.0 × 10–2 mM).  
 
3.4.2 Synthetic Experimental 
Calix[2]1,3-bis(pyrro-2-yl)(1,4)-3-methyl-5H-1,2,3-triazolium-phane 
tetrafluoroborate [3.14+·4BF4-]: Calix[2]1,3-bis(pyrro-2-yl)(1,4)-1,2,3-triazolo-phane 
(200 mg, 0.228 mmol) and trimethyloxonium tetrafluoroborate (142 mg, 0.960 mmol) 
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were placed in a 100 mL three-way round bottom flask under nitrogen protection. Then 
30 mL dry and degassed dichloromethane was added into the flask by syringe. The 
resulting solution was stirred for 3 days at room temperature under nitrogen. Methanol (5 
mL) was added into the flask and the solution was stirred for 10 mins. Evaporation of the 
reaction mixture afforded a brown solid. This brown solid was purified by column 
chromatography (silica gel, CH2Cl2 : CH3OH, 10 : 0.8, eluent) and then followed by 
recrystallization from DMF and ether to give 112 mg (38%, 0.087 mmol) of [3.14+·4BF4-] 
as a white solid. 1H NMR (DMF-d7, 400 MHz) [ppm], δ 11.80 (s, 4 H, NH), 9.35 (s, 4 H, 
-N-CH=C-), 8.45 (d, J=2.4 Hz, 4 H, CH), 8.14 (m, 2 H, CH), 7.13 (m, 4 H, pyrrole-β-H), 
6.54 (m, 4 H, pyrrole-β-H), 4.68 (s, 12 H, CH3), 1.79 (s, 12 H, CH3), 1.45 (s, 18 H, CH3); 
13C-NMR (CD3OD, 100 MHz) [ppm], δ 163.4, 157.3, 144.9, 137.6, 136.1, 122.1, 113.7, 
112.4, 107.7, 38.8, 36.1, 35.5, 30.2, 29.7, 28.5; MS (HR-ESI) Calcd. for C54H64B3N16F12 
(M-BF4-) 1197.5582; Found 1197.5600 (M-BF4-). 
 
3.4.3 Details of Fitting the UV-Vis Binding Curves 
UV-Vis Anion Recognition Study: 
Stock solutions of the host molecule being studied were made up in acetonitrile 
with the final concentrations being 1 × 10-5 M. Stock solutions of the guest in question 
were prepared by dissolving 100 - 500 equivalents of the tetrabutylammonium salts of the 
anions under study in 2 mL stock solutions of the host. Making up the anion source 
solutions in this way allowed the binding studies to be carried out without having to make 
mathematical corrections to account for changes in host concentration as the result of 
dilution effects. 
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Stock solutions of the host molecule being studied were made up in methanol 
with the final concentrations being 1 × 10-5 M. Stock solutions of the guest in question 
were prepared by dissolving 100 - 20000 equivalents of the tetrabutylammonium salts of 
the anions under study in 2 mL stock solutions of the host. Making up the anion source 
solutions in this way allowed the binding studies to be carried out without having to make 
mathematical corrections to account for changes in host concentration as the result of 
dilution effects. 
Stock solutions of the host molecule being studied were made up in 60% 
water/acetone (pH 7.2 with 5mM HEPES buffer) with the final concentrations being 5 × 
10-5 M. Stock solutions of the guest in question were prepared by dissolving 100 - 2000 
equivalents of the tetrabutylammonium salts of the anions under study in 2 mL stock 
solutions of the host. Making up the anion source solutions in this way allowed the 
binding studies to be carried out without having to make mathematical corrections to 
account for changes in host concentration as the result of dilution effects. 
The general procedure for the UV-Vis binding studies involved making sequential 
additions of titrant (anionic guest) using Hamilton pipettes to a 3 mL aliquot of the host 
stock solution in a spectrometric cell. The data was then collated and combined to 
produce plots that showed the changes in host spectral features as a function of guest 
concentration. 
 
Job Plot Construction: 
Stock solutions of the macrocycle [3.14+·4BF4-] (1.0 × 10–5 M) and the 
tetrabutylammonium anion salts (1.0 × 10–5 M) were prepared separately in acetonitrile. 
The UV-Vis spectrum was taken for each of 13 different solutions containing a total of 
3.0 mL of the macrocycle [3.14+·4BF4-] and tetrabutylammonium salt in the following 
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ratios: 3.0:0, 2.7:0.3, 2.4:0.6, 2.25:0.75, 2.0:1.0, 1.8:1.2, 1.5:1.5, 1.2:1.8, 1.0:2.0, 
0.75:2.25, 0.6:2.4, 0.3:2.7 and 0:3.0. Job’s plots were constructed by plotting Aobs–AM–
Aanion against the γ-coordinate. (γ = [host] / ([host] + [guest]))   
Stock solutions of the macrocycle [3.14+·4BF4-] (1.0 × 10–5 M) and the 
tetrabutylammonium anion salts (1.0 × 10–5 M) were prepared separately in methanol. 
The UV-Vis spectrum was taken for each of 13 different solutions containing a total of 
3.0 mL of the macrocycle [3.14+·4BF4-] and tetrabutylammonium salt in the following 
ratios: 3.0:0, 2.7:0.3, 2.4:0.6, 2.25:0.75, 2.0:1.0, 1.8:1.2, 1.5:1.5, 1.2:1.8, 1.0:2.0, 
0.75:2.25, 0.6:2.4, 0.3:2.7 and 0:3.0. Job’s plots were constructed by plotting Aobs–AM–
Aanion against the γ-coordinate. (γ = [host] / ([host] + [guest])) 
Stock solutions of the macrocycle [3.14+·4BF4-] (5.0 × 10–5 M) and the 
tetrabutylammonium anion salts (5.0 × 10–5 M) were prepared separately in 60% 
water/acetone (pH 7.2 with 5 mM HEPES buffer). The UV-Vis spectrum was taken for 
each of 13 different solutions containing a total of 3.0 mL of the macrocycle [3.14+·4BF4-] 
and tetrabutylammonium salt in the following ratios: 3.0:0, 2.7:0.3, 2.4:0.6, 2.25:0.75, 
2.0:1.0, 1.8:1.2, 1.5:1.5, 1.2:1.8, 1.0:2.0, 0.75:2.25, 0.6:2.4, 0.3:2.7 and 0:3.0. Job’s plots 
were constructed by plotting Aobs–AM–Aanion against the γ-coordinate. (γ = [host] / ([host] 
+ [guest]))   
 
Calculations of Equilibrium Constants, Ka 
Upon addition of tetrabutylammonium salts, the UV-Vis spectra changed 
gradually. These changes were ascribed to anion binding, with the corresponding 
association constants (Ka, Ka1, Ka2) being determined by nonlinear curve fitting of the 
curves obtained by plotting the absorbance changes at a λ value where the spectral 
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change was maximal (∆A) against the concentration of the tetrabutylammonium anion 
salt added, [X-]. The data was fitted to the equation, 
1:1 binding: 
∆A = A·{([3.14+·4BF4-] + [X-] + (1/Ka)) – {([3.14+·4BF4-] + [X-] + (1/Ka))2– 
(4·[3.14+·4BF4-]·[X-])}1/2} / (2·[3.14+·4BF4-])                
1:2 binding: 
∆A = (A1·[3.14+·4BF4-]·Ka1·[X-] + A2·[3.14+·4BF4-]·Ka1·Ka2·[X-]2) / (1 + Ka1·[X-
]+Ka1·Ka2·[X-]2) 
where, the unknown parameters are Ka, Ka1, Ka2,  the value of the association 
constants; these values were obtained by the fit to the data with good fits (e.g., Rˆ2  




Figure 3.7: (a) UV-Vis spectra of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3CN with increasing 
quantities of (n-Bu)4NHSO4 (0 ~ 2.0 × 10-5 M). (b) The job plot 
corresponding to the complexation between host and (n-Bu)4NHSO4 in 
CH3CN. [host + guest] = 1.00 × 10-5 M. A maximum value at 0.5 is seen; 
this is consistent with a 1:1(host : guest) binding stoichiometry. 
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Figure 3.8: (a) UV-Vis spectra of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3CN with increasing 
quantities of ((n-Bu)4N)3HP2O7 (0 ~ 4.0 × 10-5 M). (b) The job plot 
corresponding to the complexation between host and ((n-Bu)4N)3HP2O7 in 
CH3CN. [host + guest] = 1.00 × 10-5 M. A maximum value at 0.5 is seen; 
this is consistent with a 1:1 (host : guest) binding stoichiometry. 
 
Figure 3.9: (a) UV-Vis spectra of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3CN with increasing 
quantities of (n-Bu)4NH2PO4 (0 ~ 1.7 × 10-4 M). (b) The job plot 
corresponding to the complexation between host and (n-Bu)4NH2PO4 in 
CH3CN. [host + guest] = 1.00 × 10-5 M. A maximum value at 0.33 is seen; 




Figure 3.10: (a) UV-Vis spectra of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3CN with 
increasing quantities of (n-Bu)4NOAc (0 ~ 3.0 × 10-5M). (b) The job plot 
corresponding to the complexation between host and (n-Bu)4NOAc in 
CH3CN. [host + guest] = 1.00 × 10-5 M. A maximum value at 0.50 is seen; 
this is consistent with a 1:1 (host: guest) binding stoichiometry.  
 
Figure 3.11: (a) UV-Vis spectra of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3CN with 
increasing quantities of (n-Bu)4NCl (0 ~ 5.0 × 10-5 M). (b) The job plot 
corresponding to the complexation between host and (n-Bu)4NCl in CH3CN. 
[host + guest] = 1.00 × 10-5 M. A maximum value at 0.50 is seen; this is 
consistent with a 1:1 (host : guest) binding stoichiometry. 
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Figure 3.12: (a) UV-Vis spectra of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3CN with 
increasing quantities of (n-Bu)4NBr (0 ~ 1.5 × 10-4 M). (b) The job plot 
corresponding to the complexation between host and (n-Bu)4NBr in CH3CN. 
[host + guest] = 1.00 × 10-5 M. A maximum value at 0.50 is seen; this is 
consistent with a 1:1 (host : guest) binding stoichiometry. 
 
Figure 3.13: (a) UV-Vis spectra of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3CN with 
increasing quantities of (n-Bu)4NNO3 (0 ~ 5.0 × 10-5 M). (b) The job plot 
corresponding to the complexation between host and (n-Bu)4NNO3 in 
CH3CN. [host + guest] = 1.00 × 10-5 M. A maximum value at 0.5 is seen; 
this is consistent with a 1:1 (host : guest) binding stoichiometry. 
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Figure 3.14: (a) Variations in the absorbance at 380 nm (▪) of a solution of receptor 
[3.14+·4BF4-] (1.00 × 10-5 M) in CH3CN as a function of TBAHSO4 
concentration (0 ~ 2.0 × 10-5 M) at 300 K. (b) Variations in the absorbance 
(▪) at 266 nm of a solution of receptor [3.14+·4BF4-] (1.00 × 10-5 M) in 
CH3CN as a function of TBA3HP2O7 concentration (0 ~ 4.0 × 10-5 M) at 300 
K. (c) Variations in the absorbance (▪) at 290 nm of a solution of receptor 
[3.14+·4BF4-] (1.00 × 10-5 M) in CH3CN as a function of TBAH2PO4 
concentration (0 ~ 5.0 × 10-5 M) at 300 K. (d) Variations in the absorbance 
(▪) at 310 nm of a solution of receptor [3.14+·4BF4-] (1.00 × 10-5 M) in 
CH3CN as a function of TBAOAc concentration (0 ~ 3.0 × 10-5 M) at 300 K. 
(e) Variations in the absorbance (▪) at 290 nm of a solution of receptor 
[3.14+·4BF4-] (1.00 × 10-5 M) in CH3CN as a function of TBACl 
concentration (0 ~ 6.0 × 10-5 M) at 300 K. (f) Variations in the absorbance 
(▪) at 350 nm of a solution of receptor [3.14+·4BF4-] (1.00 × 10-5 M) in 
CH3CN as a function of TBABr concentration (0 ~ 6.0 × 10-5 M) at 300 K. 
(g) Variations in the absorbance (▪) at 350 nm of a solution of receptor 
[3.14+·4BF4-] (1.00 × 10-5 M) in CH3CN as a function of TBANO3 





















Table 3.3:  Anion binding constants (Ka; M-1) for the interaction of anion receptor 
[3.14+·4BF4-] with different anions in CH3CN at 300K. 
Guest Stoichiometric ratio 
Host / Guest 
Ka.1,      Ka.2 
HSO4- 1:1 Ka = ( 9.88 ± 1.18) ×106 M-1    
HP2O73- 1:1 Ka = ( 9.89  ± 1.06 ) ×105 M-1 
H2PO4- 1:2 Ka.1 = ( 6.44  ± 0.16) ×103 M-1    
Ka.2 = ( 1.03  ± 0.04) ×105 M-1 
CH3COO- 1:1 Ka = ( 2.25 ± 0.14) ×106 M-1 
NO3- 1:1 Ka = ( 5.99  ± 0.61) ×105 M-1 
Cl- 1:1 Ka = ( 4.48 ± 0.53) ×106 M-1 




Figure 3.15: (a) UV-Vis spectra of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3OH with 
increasing quantities of (n-Bu)4NHSO4 (0 ~ 3.0 × 10-5 M). (b) The job plot 
corresponding to the complexation between host and (n-Bu)4NHSO4 in 
CH3OH. [host + guest] = 1.00 × 10-5 M. A maximum value at 0.5 is seen; 
this is consistent with a 1:1 (host : guest) binding stoichiometry. 
 
Figure 3.16: (a) UV-Vis spectra of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3OH with 
increasing quantities of ((n-Bu)4N)3HP2O7 (0 ~ 2.0 × 10-5 M). (b) The job 
plot corresponding to the complexation between host and ((n-Bu)4N)3HP2O7 
in CH3OH. [host + guest] = 1.00 × 10-5 M. A maximum value at 0.5 is seen; 




Figure 3.17: (a) UV-Vis spectra of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3OH with 
increasing quantities of (n-Bu)4NH2PO4 (0 ~ 4.0 × 10-5 M). (b) The job plot 
corresponding to the complexation between host and (n-Bu)4NH2PO4 in 
CH3OH. [host + guest] = 1.00 × 10-5 M. A maximum value at 0.50 is seen; 
this is consistent with a 1:1 (host : guest) binding stoichiometry. 
 
Figure 3.18: (a) UV-Vis spectra of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3OH with 
increasing quantities of (n-Bu)4NOAc (0 ~ 2.0 × 10-3M). (b) UV-Vis spectra 
of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3OH with increasing quantities of (n-




Figure 3.19: (a) UV-Vis spectra of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3OH with 
increasing quantities of (n-Bu)4NCl (0 ~ 2.5 × 10-3 M). (b) UV-Vis spectra 
of [3.14+·4BF4-] (1.00 × 10-5 M) in CH3OH with increasing quantities of (n-









Figure 3.20: (a) Variations in the absorbance at 305 nm (▪) of a solution of receptor 
[3.14+·4BF4-] (1.00 × 10-5 M) in CH3OH as a function of TBAHSO4 
concentration (0 ~ 3.0 × 10-5 M) at 300 K. (b) Variations in the absorbance 
(▪) at 310 nm of a solution of receptor [3.14+·4BF4-] (1.00 × 10-5 M) in 
CH3OH as a function of TBA3HP2O7 concentration (0 ~ 2.0 × 10-5 M) at 300 
K. (c) Variations in the absorbance (▪) at 337 nm of a solution of receptor 
[3.14+·4BF4-] (1.00 × 10-5 M) in CH3OH as a function of TBAH2PO4 
concentration (0 ~ 4.0 × 10-5 M) at 300 K. (d) Variations in the absorbance 
(▪) at 305 nm of a solution of receptor [3.14+·4BF4-] (1.00 × 10-5 M) in 
CH3OH as a function of TBAOAc concentration (0 ~ 2.0 × 10-3 M) at 300 K. 
(e) Variations in the absorbance (▪) at 310 nm of a solution of receptor 
[3.14+·4BF4-] (1.00 × 10-5 M) in CH3OH as a function of TBACl 
concentration (0 ~ 2.5 × 10-3 M) at 300 K. (f) Variations in the absorbance 
(▪) at 308 nm of a solution of receptor [3.14+·4BF4-] (1.00 × 10-5 M) in 
CH3OH as a function of TBABr concentration (0 ~ 1.2 × 10-3 M) at 300 K. 
(g) Variations in the absorbance (▪) at 310 nm of a solution of receptor 
[3.14+·4BF4-] (1.00 × 10-5 M) in CH3OH as a function of TBANO3 
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Table 3.4: Anion binding constants (Ka; M-1) for the interaction of anion receptor 
[3.14+·4BF4-] with different anions in CH3OH at 300K. 
Guest Stoichiometric ratio 
Host / Guest 
Ka 
HSO4- 1:1 Ka = ( 1.60 ± 0.22) ×107 M-1    
HP2O73- 1:1   Ka = ( 1.17  ± 0.17 ) ×107 M-1 
H2PO4- 1:1   Ka = ( 1.73  ± 0.15) ×106 M-1 
CH3COO- 1:1   Ka = ( 1.79  ± 0.01) ×103 M-1 
NO3- 1:1   Ka = ( 7.90  ± 0.50) ×103 M-1 
Cl- 1:1   Ka = ( 2.93  ± 0.05) ×103 M-1 





Figure 3.21: (a) UV-Vis spectra of [3.14+·4BF4-] (5.00 × 10-5 M) in acetone–H2O (2 : 3) 
with increasing quantities of (n-Bu)4NHSO4 (0 ~ 6.0 × 10-5 M). The solution 
was buffered at pH 7.2 with HEPES buffer (5.00 × 10-3 M). (b) The job plot 
corresponding to the complexation between host and (n-Bu)4NHSO4 in 
acetone–H2O (2 : 3). The solution was buffered at pH 7.2 with HEPES 
buffer (5.00 × 10-3 M). [host + guest] = 5.00 × 10-5 M. A maximum value at 









Figure 3.22: (a) UV-Vis spectra of [3.14+·4BF4-] (5.00 × 10-5 M) in acetone–H2O (2 : 3) 
with increasing quantities of ((n-Bu)4N)3HP2O7 (0 ~ 8.0 × 10-5 M). The 
solution was buffered at pH 7.2 with HEPES buffer (5.00 × 10-3 M).  (b) 
The job plot corresponding to the complexation between host and ((n-
Bu)4N)3HP2O7 in acetone–H2O (2 : 3). The solution was buffered at pH 7.2 
with HEPES buffer (5.00 × 10-3 M). [host + guest] = 5.00 × 10-5 M. A 








Figure 3.23: (a) UV-Vis spectra of [3.14+·4BF4-] (5.00 × 10-5 M) in acetone–H2O (2 : 3) 
with increasing quantities of (n-Bu)4NH2PO4 (0 ~ 2.5 × 10-4 M). The 
solution was buffered at pH 7.2 with HEPES buffer (5.00 × 10-3 M). (b) The 
job plot corresponding to the complexation between host and (n-
Bu)4NH2PO4 in acetone–H2O (2 : 3). The solution was buffered at pH 7.2 
with HEPES buffer (5.00 × 10-3 M). [host + guest] = 5.00 × 10-5 M. A 











Figure 3.24: (a) Variations in the absorbance at 380 nm (▪) of a solution of receptor 
[3.14+·4BF4-] (5.00 × 10-5 M) in acetone–H2O (2 : 3) as a function of 
TBAHSO4 concentration (0 ~ 6.0 × 10-5 M) at 300 K. The solution was 
buffered at pH 7.2 with HEPES buffer (5.00 × 10-3 M).  (b) Variations in 
the absorbance (▪) at 380 nm of a solution of receptor [3.14+·4BF4-] (5.00 × 
10-5 M) in acetone–H2O (2 : 3) as a function of (TBA)3HP2O7 concentration 
(0 ~ 8.0 × 10-5 M) at 300 K. The solution was buffered at pH 7.2 with 
HEPES buffer (5.00 × 10-3 M). (c) Variations in the absorbance (▪) at 380 
nm of a solution of receptor [3.14+·4BF4-] (5.00 × 10-5 M) in acetone–H2O 
(2 : 3) as a function of TBAH2PO4 concentration (0 ~ 2.5 × 10-4 M) at 300 
K. The solution was buffered at pH 7.2 with HEPES buffer (5.00 × 10-3 M). 
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Table 3.5: Anion binding constants (Ka; M-1) for the interaction of anion receptor 
[3.14+·4BF4-] with different anions in acetone–H2O (2 : 3) at 300K. The 
solution was buffered at pH 7.2 with HEPES buffer (5.00 × 10-3 M). a n.d. = 




Host / Guest 
Ka 
HSO4- 1:1 Ka = ( 3.92 ± 0.36) ×105 M-1 
HP2O73- 1:1 Ka = ( 2.49 ± 0.15 ) ×105 M-1 
H2PO4- 1:1 Ka = ( 3.53 ± 0.14) ×104 M-1 
CH3COO- n.d.a n.d. 
NO3- n.d. n.d. 
Cl- n.d. n.d. 





3.4.4 NMR Anion Recognition Study: 
Solutions of receptor [3.14+·4BF4-] (4 mM, CD3OD, 300 K) were titrated by adding 







Figure 3.25: 1H NMR spectrum of anion receptor [3.14+·4BF4-] and 0.25, 0.50, 0.75, 1.0, 





Figure 3.26: 1H NMR spectrum of anion receptor [3.14+·4BF4-] and 0.25, 0.50, 0.75, 1.0, 










Figure 3.27: 1H NMR spectrum of anion receptor [3.14+·4BF4-] and 0.25, 0.50, 0.75, 1.0, 













Figure 3.28: 1H NMR spectrum of anion receptor [3.14+·4BF4-] and 1.0, 2.0, 3.0, 4.0, 6.0, 










Figure 3.29: 1H NMR spectrum of anion receptor [3.14+·4BF4-] and 1.0, 2.0, 3.0, 4.0, 5.0, 












Figure 3.30: 1H NMR spectrum of anion receptor [3.14+·4BF4-] and 1.0, 2.0, 3.0, 4.0, 5.0, 











Figure 3.31: 1H NMR spectrum of anion receptor [3.14+·4BF4-] and 1.0, 2.0, 3.0, 4.0, 5.0, 







Figure 3.32: Full view of the 2D COSY NMR spectrum of 3.14+·4BF4- recorded in 
CD3OD at 300 K. (The peaks at 2.74 ppm and 2.91 ppm belong to the DMF 
solvent. Macrocycle 3.14+·4BF4- was recrystallized from DMF and ether 
solvents. The DMF solvent was wrapped inside the compound and was hard 





Figure 3.33: Full view of the 2D NOESY NMR spectrum of 3.14+·4BF4- recorded in 
CD3OD at 300 K. (The peaks at 2.74 ppm and 2.91 ppm belong to the DMF 
solvent. Macrocycle 3.14+·4BF4- was recrystallized from DMF and ether 
solvents. The DMF solvent was wrapped inside the compound and was hard 











Figure 3.34: Full view of the 2D COSY NMR spectrum of 3.14+·4BF4- containing two 
equivalent TBA3HP2O7 recorded in CD3OD at 300 K. (The peak at 2.74 ppm 
and 2.91 ppm belong to the DMF solvent. Macrocycle 3.14+·4BF4- was 
recrystallized from DMF and ether solvents. The DMF solvent was wrapped 








Figure 3.35: Full view of the 2D NOESY NMR spectrum of 3.14+·4BF4- containing two 
equivalent TBA3HP2O7 recorded in CD3OD at 300 K. (The peaks at 2.74 
ppm and 2.91 ppm belong to the DMF solvent. Macrocycle 3.14+·4BF4- was 
recrystallized from DMF and ether solvents. The DMF solvent was wrapped 





3.4.5 Details of Electronic Structure Calculations 
These studies were carried out by our collaborator, Dr. Benjamin Hay, and are 
included here for the benefit of the reader, even though they are not part of the author’s 
dissertation work. 
Cartesian coordinates and absolute energies for geometries optimized with 
NWChem at the MP2/aug-cc-pVDZ level of theory using the frozen core approximation 





Energy -241.9461853 hartree 
9 
  N    0.239243    1.138535    0.001495 
  N   -1.078491    0.926712    0.001495 
  N   -1.146255   -0.406097    0.001495 
  C    0.061417   -1.030823    0.001495 
  C    0.991974    0.007126    0.002487 
  H    0.555115    2.111511   -0.000504 
  H    2.078964    0.006821   -0.000504 
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  H    0.178375   -2.111496   -0.002502 
  H   -2.078964   -0.825241    0.002487 
 
triazolium chloride complex, bound to C-H  
(C-H---Cl constrained to 180°) 
 
Energy -701.8212085 hartree 
10 
  N   -2.119019   -0.277893   -0.019836 
  N   -1.965775    1.051239   -0.098282 
  N   -0.628586    1.156158   -0.081802 
  C    0.068222   -0.009811    0.001282 
  C   -0.945557   -0.970505    0.042526 
  H   -3.071793   -0.634415   -0.014389 
  H   -0.903168   -2.053558    0.109329 
  H    1.241745   -0.008270    0.021286 
  H   -0.223953    2.091415   -0.130920 
 Cl    3.050644    0.024841    0.050232 
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3.4.6 Crystallographic Data (CIF) 
Crystals used in this study were obtained by the author. They are in the form of 
multiply intergrown, colorless needles in the case of macrocycle 3.14+•4BF4-
•CH3OH•3H2O, yellow prisms in the cases of the complex 3.14+•HP2O73-•BF4-, and yellow 
prisms in the cases of the complex 2(3.14+)•2H2PO4-•6BF4-. Diffraction grade crystals of 
macrocycle 3.14+•4BF4-•CH3OH•3H2O were obtained by vapor diffusion from diethyl 
ether to methanol. Crystals of the complex 3.14+•HP2O73-•BF4- were obtained by vapor 
diffusion from diethyl ether to methanol. Crystals of the complex 2(3.14+)•2H2PO4-•6BF4- 
were obtained by vapor diffusion from diethyl ether to methanol. The data crystals were 
cut from a cluster of crystals and had the approximate dimensions given in Table 3.6. The 
data were collected by the author on a Rigaku Saturn CCD diffractometer using a 
graphite monochromator with MoKα radiation (λ = 0.71075 Ǻ). The data were collected 
using ω-scans with a scan range of 1˚ at low temperature shows using an Oxford 
Cryostream low temperature device (cf. Table 3.6). Data reduction was performed using 
DENZO-SMN.26 The structures were solved by Dr. Xiaoping Yang via direct methods 
using SIR9727 and refined by full-matrix least-squares on F2 with anisotropic 
displacement parameters for the non-H atoms using SHELXL-97.28 The hydrogen atoms 
were calculated in ideal positions with isotropic displacement parameters set to 1.2 × Ueq 
of the attached atom (1.5 × Ueq for methyl hydrogen atoms). 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized. Definitions used for calculating 
R(F), Rw(F2) and the goodness of fit, S, are given below.29 Neutral atom scattering 
factors and values used to calculate the linear absorption coefficient are from the 
International Tables for X-ray Crystallography (1992).30 All ellipsoid figures were 
generated using SHELXTL/PC.31 Tables of positional and thermal parameters, bond 
lengths and angles, torsion angles, figures and lists of observed and calculated structure 
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factors are located in the cif documents available from the Cambridge Crystallographic 
Centre via quoting ref. numbers 849576, 849577 and 849578. These documents also 
contain details of crystal data, data collection and structure refinement.   
 
Table 3.6: X-ray crystallographic data comparison of macrocycle 3.14+•4BF4-
•CH3OH•3H2O, complex 3.14+•HP2O73-•BF4-, and complex 2(3.14+)•2H2PO4-
•6BF4- 
 








CCDC No. 849576 849577 849578 
empirical 
formula 
C55H68B4F16N16O4 C54 H64BF4N16O7P2 C162H200B8F32N48O16P4 
Fw 1364.49 1197.96 3894.06 
crystal size 
(mm3) 
0.20× 0.18 × 0.15 0.22× 0.17 × 0.10 0.21× 0.18 × 0.16 
Crystal 
system 
Monoclinic Monoclinic Monoclinic 
Space group P2(1)/n P2(1)/n P2(1)/n 
a [Ǻ] 15.7015(5) 19.726(9) 20.554(6) 
b [Ǻ] 12.8679(3) 15.697(6) 16.552(5) 






Table 3.6, cont. 
 
α [deg] 90.00 90.00 90.00 
β [deg] 105.0640(10) 101.404(6) 93.445(7) 
γ [deg] 90.00 90.00 90.00 
V / [Ǻ3] 3515.66(18) 6849(5) 10720(6) 
d / [g/cm3] 1.099 1.278 1.328 
Z 2 4 2 
T [K] 153(1) 153(1) 153(1) 
F(000) 1224 2760 4480 
μ, mm-1 0.084 0.142 0.138 
θ rang, deg 3.07-25.00 3.01-25.00   3.01-25.00 
reflns meads 31167 48859 91128 
reflns used 6166 12025 18667 
params  388 1037 1586 
R1, wR2  I > 
2ό(I) 
0.1050, 0.2782 0.0924, 0.2326 0.0981, 0.2262 
R1, wR2 (all 
data) 
0.1138, 0.2881 0.1617, 0.2684 0.1924, 0.2681 






Figure 3.36. N-H···F and C-H···F hydrogen bonded interactions in the single crystal 
structure of 3.14+•4BF4–•CH3OH•3H2O: C(8)-H···F(5): 2.399 Å, C-H-F 




Figure 3.37. N-H···O and C-H···O hydrogen bonded interactions in the single crystal 
structure of 3.14+•HP2O73–•BF4–: N(4)-H···O(5): 1.896 Å, N-H-O 170.5°; 
N(5)-H···O(7): 1.924 Å, N-H-O 168.5°; N(12)-H···O(2): 1.802 Å, N-H-O 
163.9°; N(13)-H···O(3): 1.981 Å, N-H-O 166.6°; C(50)-H···O(3): 1.969 Å, 
C-H-O 156.6°; C(53)-H···O(3): 3.337 Å, C-H-O 143.5°; C(8)-H···O(5): 
2.245 Å, C-H-O 147.5°; C(23)-H···O(7): 2.123 Å, C-H-O 150.6°; C(26)-









Figure 3.38. N-H···O and C-H···O hydrogen bonded interactions in the single crystal 
structure of 2(3.14+)•2H2PO4–•6BF4–: N(4)-H···O(4): 2.246 Å, N-H-O 136.7°; 
N(5)-H···O(4): 2.485 Å, N-H-O 123.1°; N(12)-H···O(8): 1.982 Å, N-H-O 
157.9°; N(13)-H···O(8): 2.004 Å, N-H-O 159.6°; C(8)-H···O(6): 2.661 Å, C-
H-O 145.9°; C(52)-H···O(6): 2.341 Å, C-H-O 154.7°; C(37)-H···O(7): 2.411 
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Chapter 4: Structurally Characterized Cationic Silver(I) and 
Ruthenium(II) Carbene Complexes of 1,2,3-Triazol-5-ylidenes 
 
4.1 INTRODUCTION 
N-heterocyclic carbenes (NHCs) have attracted considerable attention recently as 
ligands for use in transition metal-based catalysis,1 as promoters of organocatalysis,2 and 
in many other applications, as detailed by the Bielawski group at the University of Texas 
at Austin3a-f and by others.1b,3g
-3i
 In general, NHC complexes exhibit higher thermal 
stabilities than their phosphine analogues, an effect ascribed in part to the fact that NHC 
ligands are strong donors.4 To date, the majority of work with NHCs has focused on the 
1,3-disubstituted imidazolylidenes A and 1,4-disubstituted 1,2,4-triazolylidenes B (Chart 
1).5 Both of these species display remarkable stability, in addition to utility in catalytically 
active complexes. This enhancement has prompted efforts to explore and to develop 
NHCs with other structural features. An early example was reported by Crabtree and co-
workers in 2001, who described an abnormal NHC complex that featured an imidazole 
ring bound at the C5 position rather than at the C2 position (C, Chart 1).6 Since that time, 
several other abnormal NHC complexes derived from other nonclassic NHC ligands have 
been reported; these include the pyrazolin-4-ylidene D7 and the cyclic (alkyl)-
(amino)carbene E.8 It has also been shown recently that mesoionic carbenes (MICs) C, 
D, and F can be isolated in their free states.9 Compared to more classical NHCs, these 
MICs are relatively strong σ-donors,10 a feature that has made them of interest in terms of 





Chart 4.1:     N-Heterocyclic Carbenes, Including “Classical” NHC Systems (A, B) 















To date, relatively few reports have described the synthesis of 1,2,3-
triazolylidene-supported transition metal complexes and their application to catalyst 
studies.12,20,21 In 2008, Albrecht and co-workers first reported the synthesis of 1,2,3-
triazolylidenes (structure F; Chart 1) as highly modular precursors for a new class of 
carbenes and their coordination chemistry with a variety of transition metals (Pd, Ru, Rh, 
and Ir).12a Since then, silver complexes of these carbenes have been extensively studied. 
While we are aware of 11 reports of 1,2,3-triazolylidene silver complexes,12a-j,20 to the 
best of our knowledge none of the complexes in question have been structurally 
characterized via single-crystal X-ray diffraction analysis. In collaboration with the 
Bielawski group, we envisioned overcoming this deficiency through the use of modified 
1,2,3-triazolylidene ligands containing ancillary coordinating groups. With this 
consideration in mind, we have prepared and report here the first structurally 
characterized 1,2,3-triazolylidene silver complex 4.3, a species synthesized from the 
pyrrole-containing triazole and triazolium precursors, 4.1 and 4.2. We also report the first 
structurally characterized bis-ruthenium complex supported by a 1,2,3-triazolylidene-
containing framework. Both complexes are identified by an overall 1:2 ligand-to-metal 
stoichiometry. The Ag(I) complex was found to exist as an eight silver atom cluster, 
whereas its Ru congener proved to be a discrete bimetallic complex. The Ru(II) complex 
was explored as a ring-opening metathesis polymerization (ROMP) catalyst and, as 
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detailed below, proved active for the polymerization of norbornene when activated with 
(trimethylsilyl)-diazomethane (TMSD). 
 
4.2 RESULTS AND DISCUSSIONS 
The design of complex 4.4 was predicated on the combined use of 1,2,3-
triazolylidene donor subunits and pyrrole chelating groups. Pyrrole is known to be a 
useful ligand in catalytic systems when chelated to various transition metals.13 Its use in 
the present instance was expected to allow for the ditopic coordination of a ruthenium(II) 
center. Likewise, the incorporation of two pyrrole subunits, along with two 1,2,3-triazole 
moieties, into a single molecular framework was expected to allow for the complexation 
of two Ru(II) cations, while simplifying the synthesis of the starting metal-free form, 4.1. 
The synthesis of 4.1 has been reported earlier.14 It utilizes the “click”-type copper-
catalyzed [3+2] cycloaddition of an aryl diazide and with an alkyne-functionalized 
pyrrole to create the key triazole functionality.15 A variety of 1,2,3-triazoles bearing a 
wide range of functional groups at the 1- and 4- positions can be synthesized via the click 
reaction.16 In the present instance, dimethylsulfate was used to alkylate the 3-position of 
the simple triazole 4.1 to afford the triazolium salt 4.2 in 20% yield (Scheme 1). 
The triazolium salt 4.2 was tested as a possible carbene precursor by subjecting it 
to metalation with silver oxide in the presence of tetrabutylammonium chloride. This 
afforded the bis(triazolylidene) silver complex 4.3 in 84% yield,17 wherein the silver atom 
is attached to carbon C(5) (Scheme 1). Complex 4.3, in turn, was tested as a carbene 
transfer agent. For example, the new bisruthenium(II) complex 4.4, containing two 
triazolylidene donor groups, was prepared in 95% yield via a transmetalation procedure 
that consisted of adding [Ru(p-cymene)Cl2]2  to the silver complex 4.3 in CH2Cl2. 
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Scheme 4.1: Synthesis of Compounds 4.1-4.4 
 
 
The structures of 4.2-4.4 were elucidated by X-ray diffraction analysis (Table 
4.1). In salt 4.2, the bis-1,2,3-triazolium ligand displayed a twisted conformation with the 
two triazolium rings rotated in opposite directions relative to the central benzene ring 
(Figure 4.1). The dihedral angle between the two triazolium rings was measured to be 
53.4°. In each arm of the ligand, the triazolium and pyrrole rings were found to be nearly 
planar, with dihedral angles between the pair of triazolium and pyrrole rings being 9.1° 
and 5.4°, respectively. In complex 4.3, eight Ag+ ions are surrounded by four abnormal 
bis-1,2,3-triazolylidene ligands to form a twisted macrocycle (Figure 4.2). All eight Ag
+
 
ions have similar coordination environments, and each is coordinated to one abnormal 
NHC carbon atom and one pyrrole nitrogen atom. The C–Ag–N bond angles were nearly 
linear and range from 170.2(2)° to 176.2(3)°. The average Ag–C and Ag–N distances 
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were measured to be 2.074 and 2.088 Å, respectively, which are close to literature 
values.18  The average Ag–Ag distance between two adjacent Ag+ ions was measured to 
be 2.843 Å, which is shorter than the sum of the van der Waals radii for silver(0), 3.440 
Å, a finding consistent with a strong metal–metal interaction.19 It is also noteworthy that 
the triazolylidene and pyrrole rings appear to rotate in different directions relative to one 
another, with the dihedral angles between these two subunits varying from 26.9° to 44.4°. 
These variations are much larger than those present in the metal-free triazolium precursor 
4.2. Intramolecular π–π and C–H···π interactions are also inferred from the X-ray 
structure of 4.3 (Figure 4.2). For instance, the distances between the adjacent aryl units 
range from 3.387 to 3.576 Å. These values are consistent with interaryl interactions, 
which may add to the overall stability of the twisted macrocyclic structure. On the basis 
of the results of a microanalytic study (cf. section 4.4.2), it is believed that the key 
tetrameric structure of 4.3 is also present in the bulk material. 
 
 
Figure 4.1: Single-crystal X-ray structure of 4.2. All solvent molecules have been 
omitted for clarity. The dihedral angle between the two triazolium rings is 
53.4°. The dihedral angles between the triazolium and pyrrole rings are 9.1° 




Figure 4.2: Single-crystal X-ray structure of 4.3. All solvent molecules have been 
omitted for clarity. Short intermolecular π–π distances (X1A···X1B: 3.543 
Å, X1C···X1D: 3.387 Å, and X1E···X1F: 3.576 Å) and C–H···π 
interactions (C(68)–H···π: 2.484 Å,C–H–π: 164.6° and C(44)–H···π: 2.894 
Å and C–H–π: 111.2°) are seen in this octa-Ag(I) complex. 
 
In complex 4.4, two Ru2+ ions are present on either face of what is formally a 
ditopic ligand; they are separated from one another by 8.149 Å (Figure 4.3). Both Ru2+ 
ions have three-legged piano stool geometries, and each is coordinated to one carbene 
nucleus, one pyrrole nitrogen atom, one Cl- anion, and one cymene group. The average 
Ru–C distance is 2.035 Å, a value that is similar to that reported for other complexes in 
the literature.20 Interestingly, the bis-1,2,3-triazolylidene ligand present in complex 4.4 





Figure 4.3: Single-crystal X-ray structure of 4.4. All solvent molecules have been 
omitted for clarity. The dihedral angle between two triazolylidene rings is 
50.9°. The dihedral angles between the triazolylidene and pyrrole rings are 
3.0° (PlaneN5/PlaneN8) and 4.1° (PlaneN2/PlaneN1). Selected bond lengths and 
angles: Ru(1)–C(6) = 2.025(6) Å, Ru(1)–N(1) = 2.096(6) Å, Ru(1)–Cl(1) = 
2.432(2) Å, Ru(1)–C(centroid) = 1.708 Å; C(6)–Ru(1)–N(1) = 76.3(2)°, 
C(6)–Ru(1)–Cl(1) = 85.21(18)°, N(1)–Ru(1)–Cl(1) = 87.74(16)°. 
Proton nuclear magnetic resonance spectroscopic studies show that both 
complexes 4.3 and 4.4 are stable in DMSO-d6 solutions at 300 K. As can be seen from an 
inspection of Figure 4.4, the 1H NMR spectrum contains 14 signals corresponding to the 
ruthenium ditopic complex, which is in good agreement with the solid-state structure 
described above. A 2D-COSY NMR analysis allowed for assignment of the signals 
(Figure 4.7). Complex 4.4 displays three signals corresponding to the pyrrole ligand. 
These resonances appear at δ 7.31, 6.45, and 6.09 ppm, respectively, and are shifted to 
higher field than those of the free ligand, 4.2. The silver complex 4.3 was also analyzed 
by 1H NMR spectroscopy in DMSO-d6; this revealed a spectrum consistent with the 




Figure 4.4: 1H NMR spectrum of 4.4 in DMSO-d6 at 300 K. 
Upon completing the synthesis and characterization of the ruthenium complex 
4.4, it was tested as a ROMP catalyst.21 When (trimethylsilyl)diazomethane was added as 
an initiator,22 the complex initiated the ROMP of norbornene. The norbornene 
polymerization reaction was carried out in chlorobenzene under an atmosphere of 
nitrogen at 60 °C for 15 h with 0.5 mol % of 4.4 and 3.0 mol % of TMSD. Under these 
conditions, a 95% yield of polynorbornene was obtained (Scheme 4.2). The polymer was 
determined by gel permeation chromatography to exhibit a number average molecular 
weight of 46.3 kDa and a polydispersity index of 1.52 relative to polystyrene standards. 
The importance of the TMSD can be seen in the polymerization kinetics profiles shown 
in Figure 4.5. Although effective for norbornene, it is to be noted that the combination of 
4.4 and TMSD did not prove active for the ROMP of low-strain cyclic olefins, such as 
cyclooctene, cis,cis-1,5-cyclooctadiene, and cyclopentene. 
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In summary, we have successfully synthesized a novel 1,3,4-substituted 1,2,3-
triazolium salt that functioned as an effective precursor for the synthesis of new carbene 
complexes with silver(I) and ruthenium(II) cations. The presence of pyrrole subunits 
within the ligand framework contributes to the complexation of the Ru(II) centers in a 
ditopic fashion and gave rise to a novel bis-ruthenium complex that is capable of 
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polymerizing norbornene when activated with (trimethylsilyl)diazomethane. On the basis 
of these results, triazolylidene ligands such as those described here are expected to find 
utility both in the stabilization of new transition metal complexes and in the development 
of new catalytic systems.  
 
4.4 EXPERIMENTAL SECTION 
4.4.1 General Procedures 
All reagents and starting materials were obtained from commercial suppliers and 
used as received unless otherwise noted. Column chromatography was performed on 
silica gel (40-63 μm, Silicycle, Canada) and Alumina N (50-200 μm, Dynamic 
Adsorbents Inc., USA). Nuclear magnetic resonance (NMR) spectra were recorded on 
Varian Mercury 400, Varian Inova 500, or Varian DirectDrive 600 instruments. Low 
resolution ESI mass spectra were measured using either a Finnigan LCQ Quadrupole Ion 
Trap mass spectrometer or a Thermo LTQ-XL Linear Ion Trap mass spectrometer. High 
resolution ESI mass spectra were obtained on an Ion Spec Fourier Transform mass 
spectrometer (9.4 T). Gel permeation chromatography (GPC) was performed on a 
Viscotek system equipped with a VE 1122 pump, a VE 7510 degasser, two fluorinated 
polystyrene columns (IMBHW-3078 and I-MBLMW-3078) thermostated to 30 °C (using 
a ELDEX CH 150 column heater) and arranged in series or on a homebuilt system 
equipped with a Waters Model 510 HPLC pump, two fluorinated polystyrene columns 
(IMBHW-3078 and I-MBLMW-3078) arranged in series, and a Waters 486 Tunable 
Absorbance Detector. Molecular weight and polydispersity data are reported relative to 
polystyrene standards in tetrahydrofuran (THF). Microanalyses were performed by 
Atlantic Microlab, Inc. 
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4.4.2 Synthetic Experimental 
Synthesis of 4.2: 
A 250 mL round bottom flask was charged with 100 mL acetonitrile, 2.00 g (5.02 
mmol) of 4.1 and 3.81 g (30.15 mmol) dimethylsulfate and the resulting mixture was 
heated at reflux for 4 days. After removal of the solvent in vacuo, a brown oil was 
obtained. This crude product was purified by column chromatography (silica gel, 
CH2Cl2:CH3OH, 10:0.5, eluent) to yield 651 mg (20%, 1.00 mmol) of a white powder 
corresponding to 4.2. X-ray diffraction quality crystals were obtained by vapor diffusion 
of diethyl ether into a concentrated dimethylformamide solution. 1H NMR (DMF-d7, 400 
MHz) [ppm], δ 12.23 (s, 2H, NH), 9.97 (s, 2H, -N-CH=C-), 8.77 (t, J = 2.0 Hz, 1H, CH), 
8.55 (d, J = 2.0 Hz, 2H, CH), 7.41 (m, 2H, pyrrole-α-H), 7.13 (dd, J1 = 4.8 Hz, J2 = 1.2 
Hz, 2H, pyrrole-β-H), 6.49 (m, 2H, pyrrole-β-H), 4.73 (s, 6H, Trz-CH3), 3.53 (s, 6H, 
CH3), 1.53 (s, 9H, CH3); 13C NMR (DMF-d7, 100 MHz) [ppm], δ 157.7, 138.6, 136.9, 
125.5, 125.2, 122.5, 114.3, 114.1, 113.5, 111.3, 53.6, 40.4, 36.7, 30.9; MS (HR-ESI) 
Calcd. for C25H31N8SO4 ([M-CH3SO4]+) 539.2184; Found 539.2186 ([M-CH3SO4]+). 
 
Synthesis of 4.3: 
A 100 mL round bottom flask was charged with compound 4.2 (100 mg, 0.154 
mmol), silver oxide (71 mg, 0.308 mmol) and tetrabutylammonium chloride (86 mg, 
0.308 mmol) and a mixture of 20 mL dichloromethane and 20 mL acetonitrile. The 
resulting reaction mixture was stirred for 24 hrs at room temperature under aluminum foil 
to provide protection from ambient light. After 24 hours, the mixture was filtered through 
Celite and the solvent was removed using a rotary evaporator. A yellow solid, 
corresponding to compound 4.3, was then obtained after recrystallizing the crude residue 
from a mixture of dichloromethane and acetonitrile to yield 82 mg (84%, 0.032 mmol). 
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X-ray diffraction quality crystals were obtained by dissolving in a mixture of 
dichloromethane and acetonitrile and allowing the resulting solution to undergo slow 
evaporation. 1H NMR (CDCl3, 400 MHz) [ppm], δ 9.68 (m, 2 H, Har), 8.65 (m, 2 H, Har), 
8.47 (m, 2 H, Har), 8.01 (m, 4 H, Har), 7.79 (m, 2 H, Har), 7.14 (m, 2 H, pyrrole-H), 6.83 
(m, 2 H, pyrrole-H), 6.67 (m, 2 H, pyrrole-H), 6.57 (m, 6 H, pyrrole-H), 6.46 (m, 6 H, 
pyrrole-H), 6.34 (m, 4 H, pyrrole-H), 5.91 (m, 2 H, pyrrole-H), 4.27 (s, 12 H, Trz-CH3), 
4.11 (s, 6 H, Trz-CH3), 3.52 (s, 6 H, Trz-CH3), 1.35 (s, 18 H, CH3), 1.29 (s, 18 H, CH3); 
13C NMR (CD2Cl2, 100 MHz) [ppm], δ 159.6, 158.7, 158.2, 157.4, 156.4, 155.9, 155.1, 
152.3, 150.0, 149.1, 148.1, 141.0, 140.8, 139.8, 135.5, 132.8, 132.2, 131.2, 125.5, 124.8, 
123.2, 120.6, 116.5, 115.8, 114.6, 112.1, 111.5, 110.29, 109.2, 77.6, 59.2, 38.5, 37.4, 
35.1, 30.8, 29.7, 24.0, 19.8, 13.2, 1.6; MS (HR-ESI) Calcd. for C48H52N16Ag2 ([M/2+4H-
2Ag]2+) 533.13292; Found 533.13259 ([M/2+4H-2Ag]2+); Anal. Calcd for C96H96Ag8N32: 
C, 45.02; H, 3.78; N, 17.50. Found: C, 44.66; H, 3.81; N, 17.15. 
 
Synthesis of 4.4: 
A 100 mL round bottom flask was charged with compound 4.3 (78 mg, 0.031 
mmol) and dichloro(p-cymene) ruthenium(II) dimer (84 mg, 0.138 mmol) in 50 mL 
dichloromethane. The resulting reaction mixture was stirred for 24 hrs at room 
temperature under aluminum foil to provide protection from ambient light. The reaction 
mixture was then filtered through Celite and the solvent removed using a rotary 
evaporator. After recrystallizing from a mixture of chloroform and hexane, a yellow 
solid, corresponding to 4.4, was obtained in 95% yield (112 mg, 0.116 mmol). X-ray 
diffraction quality crystals were obtained by dissolving in a mixture of chloroform and 
hexane and allowing the resulting solution to undergo slow evaporation. 1H NMR 
(CDCl3, 400 MHz) [ppm], δ 8.80 (t, J = 2.0 Hz, 1 H, CH), 8.37 (m, 2 H, CH), 7.38 (m, 2 
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H, pyrrole-α-H), 6.47 (dd, J1 = 2.8 Hz, J2 = 0.8 Hz, 2H, pyrrole-β-H), 6.34 (m, 2H, 
pyrrole-β-H), 5.40 (d, J = 6 Hz, 2 H, CH), 5.22 (d, J = 6 Hz, 2 H, CH), 5.17 (d, J = 5.6 
Hz, 2 H, CH), 4.77 (d, J = 5.6 Hz, 2 H, CH), 4.18 (s, 6 H, Trz-CH3), 2.31 (m, 2 H, CH), 
2.05 (s, 6 H, CH3), 1.52 (s, 9 H, CH3), 0.98 (d, J = 6.8 Hz, 6 H, CH3), 0.86 (d, J = 7.2 Hz, 
6 H, CH3); 13C NMR (CD2Cl2, 100 MHz) [ppm], δ 168.7, 155.5, 147.6, 140.3, 135.3, 
128.5, 124.6, 119.5, 111.2, 105.4, 104.6, 101.40, 86.2, 86.0, 84.8, 80.3, 36.9, 36.2, 31.7, 
31.5, 22.6, 22.2, 19.3; MS (HR-ESI) Calcd. for C44H52N8Ru2 ([M-2Cl]2+) 448.11955; 
Found 448.12002 ([M-2Cl]2+). 
 
 
Figure 4.6: 1H NMR spectrum of 4.3 recorded in DMSO-d6 at 300 K. 
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Figure 4.7: (a) Full view and (b) expanded view of the 2D COSY NMR spectrum of 4.4 
recorded in DMSO-d6 at 300 K 
 
4.4.3 Ring Opening Metathesis Polymer 
Typical procedure for the ROMP of norbornene 
Inside an N2-filled dry box, a small vial was charged with 100 mg (1.062 mmol) 
of norbornene, 4.5 mL of chlorobenzene and a stir bar. The vial was sealed. A separate 
vial was charged with 5.13 mg (5.310 μmol) of catalyst 4.4 and 0.5 mL of chlorobenzene. 
The catalyst solution was then transferred to the vial containing norbornene via syringe. 
At this point 15.93 μL (31.86 μmol) (trimethylsilyl)diazomethane (TMSD, 2.0 M in 
hexanes) was added via syringe. After 15 hrs at 60 °C, 344 μL (2.655 mmol, 500 equiv 
relative to catalyst) of butyl vinyl ether was added to quench the polymerization. The 
reaction mixture was then poured into excess methanol (30 mL) with stirring; this caused 
precipitation of a white solid. After collecting the solid by filtration, it was washed with 
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fresh methanol (10 mL) three times giving the polymer 4.5 in yields up to 95%. The 
resulting polymer was analyzed by GPC and NMR spectroscopy. 
 
 
Figure 4.8: Gel permeation chromatography of polynorbornene 4.5. Its number average 
molar mass (Mn) is 46364 Daltons. Its weight average molar mass (Mw) is 
70240 Daltons. 
 
Inside an N2-filled dry box, a small vial was charged with 100 mg (1.062 mmol) 
of norbornene, 4.5 mL of chlorobenzene and a stir bar. The vial was sealed. A separate 
vial was charged with 5.13 mg (5.310 μmol) of catalyst 4.4 and 0.5 mL of chlorobenzene. 
The catalyst solution was then transferred to the vial containing norbornene via syringe. 
After 15 hrs at 60 °C, 344 μL (2.655 mmol, 500 equiv. relative to catalyst) of butyl vinyl 
ether was added to quench the polymerization. The reaction mixture was then poured into 
excess stirring methanol (30 mL), causing precipitation of a white solid. After filtering, 
the resulting solid was washed with fresh methanol (10 mL) three times to give the 
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expected polymer 4.6 in less than 1% yield. In spite of the low yield, the polymer 
obtained this way was analyzed by GPC. 
 
 
Figure 4.9: Gel permeation chromatography of polynorbornene 4.6. Its number average 




4.4.4 NMR Spectroscopic-based Kinetic Studies 
An NMR tube with a screw-cap septum top was charged inside a glovebox with 
20 mg (0.213 mmol) of norbornene and 0.7 mL of deuterated chlorobenzene. A 1 mL 
glass syringe was charged inside a glovebox with 1.03 mg (1.065 μmol) of catalyst 4.4 
and 0.3 mL of deuterated chlorobenzene. The norbornene solution was equilibrated at 
60 °C in the NMR instrument. The spectrum of the starting material was collected. Then 
the NMR tube was taken out of the NMR instrument. The catalyst 4.4 solution prepared 
before and 3.2 μL (6.390 μmol) (trimethylsilyl)diazomethane (TMSD, 2.0 M in hexanes) 
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were added into the NMR tube via syringe. Data points were collected every five minutes 
at 60 °C for five hours. Norbornene conversion was monitored by NMR spectroscopy. 
 
 
An NMR tube with a screw-cap septum top was charged inside a glovebox with 
20 mg (0.213 mmol) of norbornene and 0.7 mL of deuterated chlorobenzene. A 1 mL 
glass syringe was charged inside a glovebox with 1.03 mg (1.065 μmol) of catalyst 4.4 
and 0.3 mL of deuterated chlorobenzene. The norbornene solution was equilibrated at 
60 °C in the NMR instrument. The spectrum of the starting material was collected. Then 
the NMR tube was taken out of the NMR instrument. The catalyst 4.4 solution prepared 
before was added into the NMR tube via syringe. Data points were collected every five 




4.4.5 Crystallographic Data (CIF) 
Crystals used in this study were obtained by the author. They were in the form of 
multiply intergrown, colorless prisms in the case of compound 4.2‧DMF, yellow prisms 
in the case of the complex 4.3, and red prisms in the case of complex 4.4・3CHCl3. 
Diffraction grade crystals of compound 4.2・DMF were obtained by vapor diffusion of 
diethyl ether into a concentrated dimethyl formide solution. Crystals of the complex 4.3 
were obtained by slow evaporation from solution using a mixture of CH2Cl2 / CH3CN as 
the solvent. Crystals of the complex 4.4・3CHCl3 were obtained by slow evaporation 
from solution using a mixture of CHCl3 / hexane. The data crystals were cut from a 
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cluster of crystals and had the approximate dimensions given in Table 4.1. The data were 
collected by the author on a Rigaku Saturn CCD diffractometer using a graphite 
monochromator with MoKα radiation (λ = 0.71075 Ǻ). The data were collected using ω-
scans with a scan range of 1° at low temperature shows using an Oxford Cryostream low 
temperature device (Table 4.1). Data reduction was performed using DENZO-SMN.23 
The structures were solved by Dr. Xiaoping Yang via direct methods using SIR9724 and 
refined by full-matrix least-squares on F2 with anisotropic displacement parameters for 
the non-H atoms using SHELXL-97.25 The hydrogen atoms were calculated in ideal 
positions with isotropic displacement parameters set to 1.2×Ueq of the attached atom 
(1.5×Ueq for methyl hydrogen atoms). 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized. Definitions used for calculating 
R(F), Rw(F2) and the goodness of fit, S, are given below.26 Neutral atom scattering 
factors and values used to calculate the linear absorption coefficient are from the 
International Tables for X-ray Crystallography (1992).27 All ellipsoid figures were 
generated using SHELXTL/PC.28 Tables of positional and thermal parameters, bond 
lengths and angles, torsion angles, figures and lists of observed and calculated structure 
factors are located in the cif documents available from the Cambridge Crystallographic 
Centre via quoting ref. numbers 815272, 815273 and 815274. These documents also 







Table 4.1:  X-ray crystallographic data comparison of compound 4.2·DMF, complex   
4.3 and complex 4.4·3CHCl3. 
 compound 4.2·DMF  complex 4.3 complex 4.4·3CHCl3  
CCDC No. 815272 815273 815274 
empirical formula C29H41N9O9S2 C96H96Ag8N32 C47H55Cl11N8Ru2 
Fw 723.83 2561.01 1324.08 
crystal size (mm3) 0.20 × 0.20 × 0.20 0.20 × 0.20 × 0.20 0.20 × 0.15 × 0.15 
Crystal system Monoclinic Monoclinic Triclinic 
Space group P2(1)/c P2(1)/c P-1 
a [Å] 7.8083(10) 28.467(9) 12.278(11) 
b [Å] 24.654(3) 20.046(5) 15.409(13) 
c [Å] 18.254(3) 24.278(7) 15.539(14) 
α [deg] 90.00 90.00 86.89(4) 
β [deg] 91.028(4) 107.549(4) 79.58(4) 
γ [deg] 90.00 90.00 73.46(4) 
V / [Å3] 3513.5(8) 13209(7) 2772(4) 
d / [g/cm3] 1.368 1.288 1.587 
Z 4 4 2 
T [K] 113(1) 113(1) 113(1) 
R1, wR2 I > 2ó(I) 0.0875, 0.2304 0.0552, 0.1582 0.0700, 0.1865 
R1, wR2 (all data) 0.1101, 0.2500 0.0778, 0.1767 0.0789, 0.1949 
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